<html xmlns:v="urn:schemas-microsoft-com:vml"
xmlns:o="urn:schemas-microsoft-com:office:office"
xmlns:w="urn:schemas-microsoft-com:office:word"
xmlns:m="http://schemas.microsoft.com/office/2004/12/omml"
xmlns="http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=Content-Type content="text/html; charset=utf-8">
<meta name=ProgId content=Word.Document>
<meta name=Generator content="Microsoft Word 15">
<meta name=Originator content="Microsoft Word 15">
<link rel=File-List href="agenda1.fld/filelist.xml">
<link rel=Edit-Time-Data href="agenda1.fld/editdata.mso">
<!--[if !mso]>
<style>
v\:* {behavior:url(#default#VML);}
o\:* {behavior:url(#default#VML);}
w\:* {behavior:url(#default#VML);}
.shape {behavior:url(#default#VML);}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Author>Xu, Qiaobing</o:Author>
  <o:LastAuthor>Bell, Brandon D.</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>5</o:TotalTime>
  <o:Created>2019-09-20T13:34:00Z</o:Created>
  <o:LastSaved>2019-09-20T13:34:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>6690</o:Words>
  <o:Characters>38136</o:Characters>
  <o:Lines>317</o:Lines>
  <o:Paragraphs>89</o:Paragraphs>
  <o:CharactersWithSpaces>44737</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=themeData href="agenda1.fld/themedata.thmx">
<link rel=colorSchemeMapping href="agenda1.fld/colorschememapping.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves>false</w:TrackMoves>
  <w:TrackFormatting/>
  <w:PunctuationKerning/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-US</w:LidThemeOther>
  <w:LidThemeAsian>ZH-CN</w:LidThemeAsian>
  <w:LidThemeComplexScript>X-NONE</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <m:mathPr>
   <m:mathFont m:val="Cambria Math"/>
   <m:brkBin m:val="before"/>
   <m:brkBinSub m:val="&#45;-"/>
   <m:smallFrac m:val="off"/>
   <m:dispDef/>
   <m:lMargin m:val="0"/>
   <m:rMargin m:val="0"/>
   <m:defJc m:val="centerGroup"/>
   <m:wrapIndent m:val="1440"/>
   <m:intLim m:val="subSup"/>
   <m:naryLim m:val="undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState="false" DefUnhideWhenUsed="false"
  DefSemiHidden="false" DefQFormat="false" DefPriority="99"
  LatentStyleCount="377">
  <w:LsdException Locked="false" Priority="0" QFormat="true" Name="Normal"/>
  <w:LsdException Locked="false" Priority="9" QFormat="true" Name="heading 1"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 2"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 3"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 4"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 5"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 6"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 7"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 8"/>
  <w:LsdException Locked="false" Priority="9" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="heading 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index 9"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 1"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 2"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 3"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 4"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 5"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 6"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 7"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 8"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" Name="toc 9"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="header"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footer"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="index heading"/>
  <w:LsdException Locked="false" Priority="35" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="caption"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of figures"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="envelope return"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="footnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="line number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="page number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote reference"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="endnote text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="table of authorities"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="macro"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="toa heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Bullet 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Number 5"/>
  <w:LsdException Locked="false" Priority="10" QFormat="true" Name="Title"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Closing"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Signature"/>
  <w:LsdException Locked="false" Priority="1" SemiHidden="true"
   UnhideWhenUsed="true" Name="Default Paragraph Font"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="List Continue 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Message Header"/>
  <w:LsdException Locked="false" Priority="11" QFormat="true" Name="Subtitle"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Salutation"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Date"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text First Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Note Heading"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Body Text Indent 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Block Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="FollowedHyperlink"/>
  <w:LsdException Locked="false" Priority="22" QFormat="true" Name="Strong"/>
  <w:LsdException Locked="false" Priority="20" QFormat="true" Name="Emphasis"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Document Map"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Plain Text"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="E-mail Signature"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Top of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Bottom of Form"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Normal (Web)"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Acronym"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Address"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Cite"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Code"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Definition"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Keyboard"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Preformatted"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Sample"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Typewriter"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="HTML Variable"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="annotation subject"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="No List"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Outline List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Simple 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Classic 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Colorful 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Columns 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Grid 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 4"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 5"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 7"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table List 8"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table 3D effects 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Contemporary"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Elegant"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Professional"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Subtle 2"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 1"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Table Web 3"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Balloon Text"/>
  <w:LsdException Locked="false" Priority="39" Name="Table Grid"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Placeholder Text"/>
  <w:LsdException Locked="false" Priority="1" QFormat="true" Name="No Spacing"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 1"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 1"/>
  <w:LsdException Locked="false" SemiHidden="true" Name="Revision"/>
  <w:LsdException Locked="false" Priority="34" QFormat="true"
   Name="List Paragraph"/>
  <w:LsdException Locked="false" Priority="29" QFormat="true" Name="Quote"/>
  <w:LsdException Locked="false" Priority="30" QFormat="true"
   Name="Intense Quote"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 1"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 1"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 1"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 1"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 1"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 2"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 2"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 2"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 2"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 2"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 2"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 3"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 3"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 3"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 3"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 3"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 3"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 4"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 4"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 4"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 4"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 4"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 4"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 5"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 5"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 5"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 5"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 5"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 5"/>
  <w:LsdException Locked="false" Priority="60" Name="Light Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="61" Name="Light List Accent 6"/>
  <w:LsdException Locked="false" Priority="62" Name="Light Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="63" Name="Medium Shading 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="64" Name="Medium Shading 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="65" Name="Medium List 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="66" Name="Medium List 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="67" Name="Medium Grid 1 Accent 6"/>
  <w:LsdException Locked="false" Priority="68" Name="Medium Grid 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="69" Name="Medium Grid 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="70" Name="Dark List Accent 6"/>
  <w:LsdException Locked="false" Priority="71" Name="Colorful Shading Accent 6"/>
  <w:LsdException Locked="false" Priority="72" Name="Colorful List Accent 6"/>
  <w:LsdException Locked="false" Priority="73" Name="Colorful Grid Accent 6"/>
  <w:LsdException Locked="false" Priority="19" QFormat="true"
   Name="Subtle Emphasis"/>
  <w:LsdException Locked="false" Priority="21" QFormat="true"
   Name="Intense Emphasis"/>
  <w:LsdException Locked="false" Priority="31" QFormat="true"
   Name="Subtle Reference"/>
  <w:LsdException Locked="false" Priority="32" QFormat="true"
   Name="Intense Reference"/>
  <w:LsdException Locked="false" Priority="33" QFormat="true" Name="Book Title"/>
  <w:LsdException Locked="false" Priority="37" SemiHidden="true"
   UnhideWhenUsed="true" Name="Bibliography"/>
  <w:LsdException Locked="false" Priority="39" SemiHidden="true"
   UnhideWhenUsed="true" QFormat="true" Name="TOC Heading"/>
  <w:LsdException Locked="false" Priority="41" Name="Plain Table 1"/>
  <w:LsdException Locked="false" Priority="42" Name="Plain Table 2"/>
  <w:LsdException Locked="false" Priority="43" Name="Plain Table 3"/>
  <w:LsdException Locked="false" Priority="44" Name="Plain Table 4"/>
  <w:LsdException Locked="false" Priority="45" Name="Plain Table 5"/>
  <w:LsdException Locked="false" Priority="40" Name="Grid Table Light"/>
  <w:LsdException Locked="false" Priority="46" Name="Grid Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="Grid Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="Grid Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="Grid Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="Grid Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="Grid Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="Grid Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="46" Name="List Table 1 Light"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark"/>
  <w:LsdException Locked="false" Priority="51" Name="List Table 6 Colorful"/>
  <w:LsdException Locked="false" Priority="52" Name="List Table 7 Colorful"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 1"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 1"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 1"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 1"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 1"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 2"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 2"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 2"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 2"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 2"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 3"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 3"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 3"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 3"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 3"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 4"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 4"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 4"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 4"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 4"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 5"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 5"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 5"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 5"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 5"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked="false" Priority="46"
   Name="List Table 1 Light Accent 6"/>
  <w:LsdException Locked="false" Priority="47" Name="List Table 2 Accent 6"/>
  <w:LsdException Locked="false" Priority="48" Name="List Table 3 Accent 6"/>
  <w:LsdException Locked="false" Priority="49" Name="List Table 4 Accent 6"/>
  <w:LsdException Locked="false" Priority="50" Name="List Table 5 Dark Accent 6"/>
  <w:LsdException Locked="false" Priority="51"
   Name="List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked="false" Priority="52"
   Name="List Table 7 Colorful Accent 6"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Hyperlink"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Hashtag"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Unresolved Mention"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Link"/>
  <w:LsdException Locked="false" SemiHidden="true" UnhideWhenUsed="true"
   Name="Smart Link Error"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342208091 0 0 415 0;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;
	mso-font-alt:"ＭＳ ゴシック";
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1107305727 0 0 415 0;}
@font-face
	{font-family:DengXian;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:等线;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610612033 953122042 22 0 262159 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536859905 -1073697537 9 0 511 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:"Bauhaus 93";
	panose-1:4 3 9 5 2 11 2 2 12 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Roberts;
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-alt:Cambria;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:auto;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:"Edwardian Script ITC";
	panose-1:3 3 3 2 4 7 7 13 8 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"\@DengXian";
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610612033 953122042 22 0 262159 0;}
@font-face
	{font-family:"\@MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:8.0pt;
	margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:DengXian;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:ZH-CN;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-priority:99;
	mso-style-link:"Header Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.25in right 6.5in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:DengXian;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:ZH-CN;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-priority:99;
	mso-style-link:"Footer Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:center 3.25in right 6.5in;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:DengXian;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:ZH-CN;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	color:#0563C1;
	mso-themecolor:hyperlink;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-noshow:yes;
	mso-style-priority:99;
	color:#954F72;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:ZH-CN;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Balloon Text Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	mso-fareast-font-family:DengXian;
	mso-fareast-theme-font:minor-fareast;
	mso-fareast-language:ZH-CN;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParagraphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListParagraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagraphCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:EN-US;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Balloon Text";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Segoe UI",sans-serif;
	mso-ascii-font-family:"Segoe UI";
	mso-hansi-font-family:"Segoe UI";
	mso-bidi-font-family:"Segoe UI";}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Header;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Footer;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:11.0pt;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:DengXian;
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:ZH-CN;}
.MsoPapDefault
	{mso-style-type:export-only;
	margin-bottom:8.0pt;
	line-height:107%;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("agenda1.fld/header.html") fs;
	mso-footnote-continuation-separator:url("agenda1.fld/header.html") fcs;
	mso-endnote-separator:url("agenda1.fld/header.html") es;
	mso-endnote-continuation-separator:url("agenda1.fld/header.html") ecs;}
@page WordSection1
	{size:8.5in 11.0in;
	margin:1.0in .75in 1.0in .75in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;}
@page WordSection2
	{size:8.5in 11.0in;
	margin:1.0in .75in 1.0in .75in;
	mso-header-margin:.5in;
	mso-footer-margin:.5in;
	mso-paper-source:0;}
div.WordSection2
	{page:WordSection2;}
 /* List Definitions */
 @list l0
	{mso-list-id:804935302;
	mso-list-type:hybrid;
	mso-list-template-ids:-827030598 -447459188 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l0:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:40.5pt;
	text-indent:-.25in;
	mso-ansi-font-weight:normal;}
@list l0:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:76.5pt;
	text-indent:-.25in;}
@list l0:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:112.5pt;
	text-indent:-9.0pt;}
@list l0:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:148.5pt;
	text-indent:-.25in;}
@list l0:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:184.5pt;
	text-indent:-.25in;}
@list l0:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:220.5pt;
	text-indent:-9.0pt;}
@list l0:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:256.5pt;
	text-indent:-.25in;}
@list l0:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:292.5pt;
	text-indent:-.25in;}
@list l0:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:328.5pt;
	text-indent:-9.0pt;}
@list l1
	{mso-list-id:1197429514;
	mso-list-type:hybrid;
	mso-list-template-ids:-203146370 -123982484 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l1:level1
	{mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l1:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;}
@list l1:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:1.75in;
	text-indent:-9.0pt;}
@list l1:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;}
@list l1:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;}
@list l1:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:3.25in;
	text-indent:-9.0pt;}
@list l1:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;}
@list l1:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;}
@list l1:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:4.75in;
	text-indent:-9.0pt;}
@list l2
	{mso-list-id:1842503849;
	mso-list-type:hybrid;
	mso-list-template-ids:1368190098 540036094 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l2:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Calibri;
	mso-bidi-theme-font:minor-latin;
	mso-ansi-font-weight:normal;
	mso-ansi-font-style:normal;}
@list l2:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l2:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l2:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l2:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l2:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l2:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l2:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l2:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l3
	{mso-list-id:1862549599;
	mso-list-type:hybrid;
	mso-list-template-ids:1616407182 67698703 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l3:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l3:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l3:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l3:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l3:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l3:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l3:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l3:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l3:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l4
	{mso-list-id:1879194575;
	mso-list-type:hybrid;
	mso-list-template-ids:-235772498 317094000 67698713 67698715 67698703 67698713 67698715 67698703 67698713 67698715;}
@list l4:level1
	{mso-level-start-at:2;
	mso-level-text:%1;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l4:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;}
@list l4:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:1.75in;
	text-indent:-9.0pt;}
@list l4:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;}
@list l4:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;}
@list l4:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:3.25in;
	text-indent:-9.0pt;}
@list l4:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;}
@list l4:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;}
@list l4:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	margin-left:4.75in;
	text-indent:-9.0pt;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin-top:0in;
	mso-para-margin-right:0in;
	mso-para-margin-bottom:8.0pt;
	mso-para-margin-left:0in;
	line-height:107%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:minor-bidi;
	mso-fareast-language:ZH-CN;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext="edit" spidmax="1035"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext="edit">
  <o:idmap v:ext="edit" data="1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=EN-US link="#0563C1" vlink="#954F72" style='tab-interval:.5in'>

<div class=WordSection1>

<p class=MsoNormal align=center style='text-align:center'><!--[if gte vml 1]><o:wrapblock><v:shapetype
  id="_x0000_t75" coordsize="21600,21600" o:spt="75" o:preferrelative="t"
  path="m@4@5l@4@11@9@11@9@5xe" filled="f" stroked="f">
  <v:stroke joinstyle="miter"/>
  <v:formulas>
   <v:f eqn="if lineDrawn pixelLineWidth 0"/>
   <v:f eqn="sum @0 1 0"/>
   <v:f eqn="sum 0 0 @1"/>
   <v:f eqn="prod @2 1 2"/>
   <v:f eqn="prod @3 21600 pixelWidth"/>
   <v:f eqn="prod @3 21600 pixelHeight"/>
   <v:f eqn="sum @0 0 1"/>
   <v:f eqn="prod @6 1 2"/>
   <v:f eqn="prod @7 21600 pixelWidth"/>
   <v:f eqn="sum @8 21600 0"/>
   <v:f eqn="prod @7 21600 pixelHeight"/>
   <v:f eqn="sum @10 21600 0"/>
  </v:formulas>
  <v:path o:extrusionok="f" gradientshapeok="t" o:connecttype="rect"/>
  <o:lock v:ext="edit" aspectratio="t"/>
 </v:shapetype><v:shape id="Picture_x0020_16" o:spid="_x0000_s1034" type="#_x0000_t75"
  style='position:absolute;left:0;text-align:left;margin-left:0;margin-top:18.5pt;
  width:255.85pt;height:49.5pt;z-index:251670528;visibility:visible;
  mso-wrap-style:square;mso-width-percent:0;mso-height-percent:0;
  mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
  mso-wrap-distance-bottom:0;mso-position-horizontal:center;
  mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
  mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
  mso-width-relative:page;mso-height-relative:page'>
  <v:imagedata src="agenda1.fld/image001.jpg" o:title=""/>
  <w:wrap type="topAndBottom" anchorx="margin"/>
 </v:shape><![endif]--><![if !vml]><img width=256 height=50
 src="agenda1.fld/image001.jpg" v:shapes="Picture_x0020_16"><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<b style='mso-bidi-font-weight:normal'><span style='font-size:26.0pt;
line-height:107%;font-family:"Bauhaus 93";mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin;color:#C00000;background:white'>The 17th
International Nanomedicine and Drug Delivery Symposium (NanoDDS'19)<o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center'><span
style='font-size:26.0pt;line-height:107%;font-family:"Bauhaus 93";mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin;color:black;background:white'>Program
Guide<o:p></o:p></span></p>

<p class=MsoNormal align=center style='text-align:center'><span
style='mso-no-proof:yes'><!--[if gte vml 1]><v:shape id="Picture_x0020_14"
 o:spid="_x0000_i1025" type="#_x0000_t75" alt="bos" style='width:387pt;
 height:224pt;visibility:visible;mso-wrap-style:square'>
 <v:imagedata src="agenda1.fld/image002.png" o:title="bos"/>
</v:shape><![endif]--><![if !vml]><img width=387 height=224
src="agenda1.fld/image002.png" alt=bos v:shapes="Picture_x0020_14"><![endif]></span><span
style='font-size:16.0pt;line-height:107%;font-family:Helvetica;color:black;
background:white'><o:p></o:p></span></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='font-size:16.0pt;font-family:Helvetica;color:black;background:white'>Conference
Chairs:<o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='font-size:16.0pt;font-family:Helvetica;color:black;background:white'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;font-family:Helvetica;color:black;background:white'>Daniel
Anderson<o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><span style='font-size:14.0pt;font-family:
Helvetica;color:black;background:white'>Associate Professor, Chemical
Engineering and Institute for Medical Engineering and Science, Massachusetts
Institute of Technology<o:p></o:p></span></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><span style='font-size:14.0pt;font-family:
Helvetica;color:black;background:white'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='font-size:14.0pt;font-family:Helvetica;color:black;background:white'>Qiaobing
Xu<o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><span style='font-size:14.0pt;font-family:
Helvetica;color:black;background:white'>Associate Professor, Department of
Biomedical Engineering, <o:p></o:p></span></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><span style='font-size:14.0pt;font-family:
Helvetica;color:black;background:white'>Tufts University<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='font-size:16.0pt;
font-family:Helvetica;color:black;background:white'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><span style='font-size:14.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin;color:black;background:white;
mso-bidi-font-weight:bold'>MIT, Kresge Auditorium, Cambridge, MA<o:p></o:p></span></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><span style='font-size:14.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin;color:black;background:white;
mso-bidi-font-weight:bold'>September 22-24, 2019, </span><a
href="http://www.nanodds2019.org"><span style='font-size:14.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin;background:white'>http://www.nanodds2019.org</span></a><span
style='font-size:14.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;
color:black;background:white'><o:p></o:p></span></p>

<b style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;
font-family:"Calibri",sans-serif;mso-ascii-theme-font:minor-latin;mso-fareast-font-family:
DengXian;mso-fareast-theme-font:minor-fareast;mso-hansi-theme-font:minor-latin;
mso-bidi-theme-font:minor-latin;mso-ansi-language:EN-US;mso-fareast-language:
ZH-CN;mso-bidi-language:AR-SA'><br clear=all style='page-break-before:always'>
</span></b>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><!--[if gte vml 1]><v:shapetype id="_x0000_t202"
 coordsize="21600,21600" o:spt="202" path="m,l,21600r21600,l21600,xe">
 <v:stroke joinstyle="miter"/>
 <v:path gradientshapeok="t" o:connecttype="rect"/>
</v:shapetype><v:shape id="_x0000_s1033" type="#_x0000_t202" style='position:absolute;
 left:0;text-align:left;margin-left:21.5pt;margin-top:33.05pt;width:462.5pt;
 height:27.75pt;z-index:251661312;visibility:visible;mso-wrap-style:square;
 mso-width-percent:0;mso-height-percent:200;mso-wrap-distance-left:9pt;
 mso-wrap-distance-top:3.6pt;mso-wrap-distance-right:9pt;
 mso-wrap-distance-bottom:3.6pt;mso-position-horizontal:absolute;
 mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
 mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:200;
 mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
 o:gfxdata="UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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" stroked="f">
 <v:textbox style='mso-fit-shape-to-text:t'>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:
    .0001pt;text-align:center;line-height:normal;background:#E7E6E6;mso-background-themecolor:
    background2'><b style='mso-bidi-font-weight:normal'><span style='font-size:
    16.0pt;color:black;mso-color-alt:windowtext'>DAY 1, Sunday, September 22,
    2019</span></b><b style='mso-bidi-font-weight:normal'><span
    style='font-size:16.0pt'><o:p></o:p></span></b></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap type="square" anchorx="margin"/>
</v:shape><![endif]--><![if !vml]><img width=467 height=32
src="agenda1.fld/image003.png" align=left hspace=12 vspace=5
alt="Text Box: DAY 1, Sunday, September 22, 2019" v:shapes="_x0000_s1033"><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:22.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Agenda<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>7:00
am - 8:15 am<span style='mso-tab-count:1'>         </span>Registration &amp;
Breakfast<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>8:15
am - 8:30 am<span style='mso-tab-count:1'>         </span>Opening Remarks &amp;
Welcome by conference chair Daniel Anderson, MIT<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Session 1<span
style='mso-tab-count:1'>          </span>Chairs: Bing Xu (Brandeis Univ) &amp; Rajagopal
Ramesh (OUHSC) <o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>8:30am
- 9:00 am: <span style='mso-tab-count:1'>        </span>Electrostatic
Nanoparticle Platforms for Deep Tissue Penetration and Delivery<span
style='mso-tab-count:1'>    </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Paula Hammond</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>, David H.
Koch Professor in Engineering, MIT<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>9:00
am - 9:30 am<span style='mso-spacerun:yes'>  </span><span style='mso-tab-count:
1'>       </span>Bioengineered silk-elastin systems for biomedical utility<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>David Kaplan</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>, Stern
Family Professor of Biomedical Engineering, Tufts University<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>9:30
am -10:00 am <a name="_Hlk16620098"><span style='mso-tab-count:1'>       </span>New
delivery vehicles for gene editing enzymes<o:p></o:p></a></span></p>

<span style='mso-bookmark:_Hlk16620098'></span>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Niren Murthy</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>, <span
style='mso-tab-count:1'>  </span>Professor of Bioengineering, University of
California at Berkeley<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>10:00
am - 10:30 am<span style='mso-tab-count:1'>     </span>Coffee Break<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>10:30
am - 11:00 am <span style='mso-spacerun:yes'> </span><span style='mso-tab-count:
1'>    </span></span><span style='mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Engineering the
activation of natural and synthetic T cells with nanomaterials<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Darrell Irvine</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>, Professor
of Materials Science &amp; Engineering and Biological Engineering, <span
style='mso-spacerun:yes'> </span>MIT <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>11:00
am - 11:30 am <span style='mso-spacerun:yes'> </span><span style='mso-tab-count:
1'>    </span></span><span style='mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Engineering exosomes
to create transformative drugs<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Tony&nbsp;De&nbsp;Fougerolles</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>​, CEO,
Evox Therapeutics<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>11:30
am - 12:00 pm<span style='mso-tab-count:1'>     </span>Development of a
Platform for Exosome Engineering and Large-Scale Manufacturing<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Konstantin Konstantinov</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>, Executive
Vice President, Codiak BioSciences<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>12:00
pm - 1:30 pm<span style='mso-tab-count:1'>       </span>Lunch Break &amp;
Poster Session<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Session 2 <span
style='mso-tab-count:1'>         </span>Chairs: Haiquan Mao (JHU) &amp; Yizhou
Dong (Ohio State Univ) &amp; Arturo Vegas (BU)<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1:30
pm - 2:00 pm<span style='mso-tab-count:1'>         </span><span
style='color:black'>Macrophage Reprogramming with Nano-Delivery for Cancer and
Inflammatory Diseases<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Mansoor Amiji,</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> University
professor, Northeastern University<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:1.5in;margin-bottom:.0001pt;text-indent:-1.5in;line-height:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>2:00 pm -
2:30 pm<span style='mso-tab-count:1'>         </span><a name="_Hlk17104474">Avoiding
the endosomal trap: Direct cytosolic delivery of&nbsp;proteins (including
CRISPR/Cas9) through membrane fusion processes<o:p></o:p></a></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk17104474'><b style='mso-bidi-font-weight:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Vincent
Rotello,</span></b></span><span style='mso-bookmark:_Hlk17104474'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> Charles
A. Goessmann Professor of Chemistry, University of Massachusetts at Amherst<o:p></o:p></span></span></p>

<span style='mso-bookmark:_Hlk17104474'></span>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>2:30
pm - 3:00 pm<span style='mso-tab-count:1'>         </span></span><span
style='mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Polymeric Nanoparticles for&nbsp;Intracellular
Delivery&nbsp;and Cellular Programming<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Jordan Green, </span></b><span
style='mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin;color:black'>Professor of Biomedical
Engineering, Johns Hopkins University School of Medicine</span><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>3:00
pm - 3:30 pm<span style='mso-tab-count:1'>         </span>Coffee Break<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>3:30
-pm - 4:00 pm<span style='mso-tab-count:1'>        </span></span><span
style='mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>HiFi molecular transmission via crisscross
cooperativity<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-spacerun:yes'> </span><b style='mso-bidi-font-weight:normal'>William
Shih,</b> Professor, Wyss Institute/Harvard Medical School<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>4:00
pm - 4:30 pm<span style='mso-tab-count:1'>         </span></span><span
style='mso-fareast-font-family:"Times New Roman";mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Modulating inflammation with nanoparticle
payloads<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Matthias Nahrendorf,</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> Professor
of Radiology, MGH/Harvard Medical School<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>4:30
pm - 5:00 pm<span style='mso-tab-count:1'>         </span>Non-invasive drug and
gene delivery to the brain<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Justin Hanes,</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> Lewis J.
Ort Professor of Ophthalmology, Johns Hopkins University School of Medicine<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>5:00
pm -5:30 pm<span style='mso-tab-count:1'>         </span>Ultra-high capacity
polymeric micelles for drug delivery<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Alexander Kabanov</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>, the
Mescal S. Ferguson Distinguished Professor, Eshelman School of Pharmacy,
University of North Carolina at Chapel Hill<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>5:30
pm – 7:30 pm<span style='mso-tab-count:1'>        </span>Welcome Reception<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><!--[if gte vml 1]><v:shape id="Text_x0020_Box_x0020_2" o:spid="_x0000_s1032"
 type="#_x0000_t202" style='position:absolute;margin-left:16.75pt;margin-top:23.6pt;
 width:462.5pt;height:27.75pt;z-index:251659264;visibility:visible;
 mso-wrap-style:square;mso-width-percent:0;mso-height-percent:200;
 mso-wrap-distance-left:9pt;mso-wrap-distance-top:3.6pt;
 mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:3.6pt;
 mso-position-horizontal:absolute;mso-position-horizontal-relative:margin;
 mso-position-vertical:absolute;mso-position-vertical-relative:text;
 mso-width-percent:0;mso-height-percent:200;mso-width-relative:margin;
 mso-height-relative:margin;v-text-anchor:top' o:gfxdata="UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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" stroked="f">
 <v:textbox style='mso-fit-shape-to-text:t'>
  <![if !mso]>
  <table cellpadding=0 cellspacing=0 width="100%">
   <tr>
    <td><![endif]>
    <div>
    <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:
    .0001pt;text-align:center;line-height:normal;background:#E7E6E6;mso-background-themecolor:
    background2'><b style='mso-bidi-font-weight:normal'><span style='font-size:
    16.0pt;color:black;mso-color-alt:windowtext'>DAY 2, Monday, September 23,
    2019</span></b><b style='mso-bidi-font-weight:normal'><span
    style='font-size:16.0pt'><o:p></o:p></span></b></p>
    </div>
    <![if !mso]></td>
   </tr>
  </table>
  <![endif]></v:textbox>
 <w:wrap type="square" anchorx="margin"/>
</v:shape><![endif]--><![if !vml]><img width=467 height=32
src="agenda1.fld/image004.png" align=left hspace=12 vspace=5
alt="Text Box: DAY 2, Monday, September 23, 2019" v:shapes="Text_x0020_Box_x0020_2"><![endif]><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>7:00
am - 8:15 am<span style='mso-tab-count:1'>         </span>Registration &amp;
Breakfast<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><a name="_Hlk19021899"><b
style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Session 3<span style='mso-tab-count:1'>          </span>
Chairs: Akin Akinc (Alnylam) &amp; Phil Snyder (Vertex)<span style='mso-tab-count:
1'>      </span><o:p></o:p></span></b></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><span style='mso-tab-count:1'>            </span><o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:1.5in;margin-bottom:.0001pt;text-indent:-1.5in;line-height:normal'><span
style='mso-bookmark:_Hlk19021899'><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>8:15 am - 8:45 am <span style='mso-tab-count:
1'>        </span>From Microtechnology to Nanotechnology: New Ways to Discover
and Deliver Medicine to Treat Disease<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><b style='mso-bidi-font-weight:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Robert
Langer</span></b></span><span style='mso-bookmark:_Hlk19021899'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>,
Institute Professor, MIT<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>8<a name="_Hlk18572559">:45 am - 9:15
am<span style='mso-tab-count:1'>         </span><span style='mso-bidi-font-style:
italic'>In Vivo</span> CRISPR Gene Editing by Lipid Nanoparticles<o:p></o:p></a></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><span style='mso-bookmark:_Hlk18572559'><b
style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Andrew Schiermeier, </span></b></span></span><span
style='mso-bookmark:_Hlk19021899'><span style='mso-bookmark:_Hlk18572559'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Chief
Operating Officer, Intellia Therapeutics<o:p></o:p></span></span></span></p>

<span style='mso-bookmark:_Hlk18572559'></span>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><a name="_Hlk19534037"><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>9:15 am
-9:45 am<span style='mso-tab-count:1'>          </span></span></a></span><span
style='mso-bookmark:_Hlk19021899'><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Coffee Break<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><a name="_Hlk19532584"><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>9:45 am -
10:15 am<span style='mso-tab-count:1'>       </span>Breaking the Druggability
Barrier using Helicons<o:p></o:p></span></a></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><span style='mso-bookmark:_Hlk19532584'><b
style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Gregory Verdine</span></b></span></span><span
style='mso-bookmark:_Hlk19021899'><span style='mso-bookmark:_Hlk19532584'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>,
Chairman; President and CEO, Fog Pharma<o:p></o:p></span></span></span></p>

<span style='mso-bookmark:_Hlk19532584'></span>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>10:15 am - 10:45 am<span
style='mso-tab-count:1'>     </span>Gene editing therapies for inherited
retinal diseases<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><b style='mso-bidi-font-weight:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Charlie
Albright,</span></b></span><span style='mso-bookmark:_Hlk19021899'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> Chief
Scientific Officer, Editas Medicine<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:1.5in;margin-bottom:.0001pt;text-indent:-1.5in;line-height:normal'><span
style='mso-bookmark:_Hlk19021899'><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>10:45 am - 11:15 am<span style='mso-tab-count:
1'>     </span>Applications of Nanosensors to Understanding Biochemical
Signaling Within the Human Body<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><b style='mso-bidi-font-weight:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Michael
Strano</span></b></span><span style='mso-bookmark:_Hlk19021899'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>, Carbon
P. Dubbs Professor in Chemical Engineering, MIT<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>11:15 am - 11:45 am<span
style='mso-tab-count:1'>     </span>Pioneering new medicinal platforms for
targeted delivery – an ecosystem view<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19021899'><b style='mso-bidi-font-weight:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Noubar
Afeyan</span></b></span><span style='mso-bookmark:_Hlk19021899'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>, Founder
&amp; CEO, Flagship Pioneering<o:p></o:p></span></span></p>

<span style='mso-bookmark:_Hlk19021899'></span>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>11:45
am - 1:30 pm<span style='mso-tab-count:1'>       </span>Lunch Break &amp;
Poster Session<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Session 4<span
style='mso-tab-count:1'>          </span>Chairs: Daniel Anderson (MIT) &amp;
Sekar Kathiresan (Verve Tx) &amp; Shawn Chen (NIH)<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a name="_Hlk19533918"><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>1:30 pm - 2:00 pm<span style='mso-tab-count:
1'>         </span>The New Science of Therapeutics - Advanced Therapeutic
Platforms<o:p></o:p></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><b style='mso-bidi-font-weight:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Jay
Bradner</span></b></span><span style='mso-bookmark:_Hlk19533918'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>, President,
Novartis Institutes for BioMedical Research (NIBR)<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><a name="_Hlk19532978"><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>2:00 pm -
2:30 pm</span></a></span><span style='mso-bookmark:_Hlk19533918'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>         </span>Advances in RNAi Therapeutics Platform <o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><b style='mso-bidi-font-weight:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Vasant
Jadhav,</span></b></span><span style='mso-bookmark:_Hlk19533918'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> Vice
President, Alnylam Pharmaceutics<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:1.5in;margin-bottom:.0001pt;text-indent:-1.5in;line-height:normal'><span
style='mso-bookmark:_Hlk19533918'><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>2:30 pm - 3:00 pm<span style='mso-tab-count:
1'>         </span>Advancing the delivery of LNP-encapsulated mRNA therapeutics
for the treatment of genetic diseases <o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><b style='mso-bidi-font-weight:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Ronald
C. Renaud Jr.,</span></b></span><span style='mso-bookmark:_Hlk19533918'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> Chief
Executive Officer, Translate Bio<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><a name="_Hlk19532252"><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>3:00 pm -
3:30 pm </span></a></span><span style='mso-bookmark:_Hlk19533918'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>        </span></span></span><span style='mso-bookmark:
_Hlk19533918'><span style='mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Industrialization
of mRNA medicines<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><a name="_Hlk19532268"><b
style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Stéphane</span></b></a></span><span
style='mso-bookmark:_Hlk19533918'><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> Bancel</span></b></span><span
style='mso-bookmark:_Hlk19533918'><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>, Chief Executive Officer, Moderna Inc.<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>3:30 -pm - 4:00 pm<span
style='mso-tab-count:1'>        </span>coffee break<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><a name="_Hlk19532043"><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>4:00 pm -
4:30 pm</span></a></span><span style='mso-bookmark:_Hlk19533918'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>         </span></span></span><span style='mso-bookmark:
_Hlk19533918'><span style='mso-fareast-font-family:"Times New Roman";
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Activity-based
nano sensors as synthetic biomarkers of disease<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><b style='mso-bidi-font-weight:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Sangeeta
Bhatia,</span></b></span><span style='mso-bookmark:_Hlk19533918'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> John J.
and Dorothy Wilson Professor of Engineering, MIT<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><a name="_Hlk19531959"><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>4:30 pm -
5:00 pm</span></a></span><span style='mso-bookmark:_Hlk19533918'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>         </span>Bringing CRISPR to the clinic<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19533918'><b style='mso-bidi-font-weight:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Tony
Ho,</span></b></span><span style='mso-bookmark:_Hlk19533918'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> Executive
Vice President, CRISPR Therapeutics<o:p></o:p></span></span></p>

<span style='mso-bookmark:_Hlk19533918'></span>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>5:00
pm – 7:30 pm<span style='mso-tab-count:1'>        </span>Networking Event<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><!--[if gte vml 1]><o:wrapblock><v:shape id="_x0000_s1031" type="#_x0000_t202"
  style='position:absolute;margin-left:0;margin-top:28.25pt;width:492.5pt;
  height:27.75pt;z-index:251663360;visibility:visible;mso-wrap-style:square;
  mso-width-percent:0;mso-height-percent:200;mso-wrap-distance-left:9pt;
  mso-wrap-distance-top:3.6pt;mso-wrap-distance-right:9pt;
  mso-wrap-distance-bottom:3.6pt;mso-position-horizontal:left;
  mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
  mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:200;
  mso-width-relative:margin;mso-height-relative:margin;v-text-anchor:top'
  o:gfxdata="UEsDBBQABgAIAAAAIQC2gziS/gAAAOEBAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbJSRQU7DMBBF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" stroked="f">
  <v:textbox style='mso-fit-shape-to-text:t'>
   <![if !mso]>
   <table cellpadding=0 cellspacing=0 width="100%">
    <tr>
     <td><![endif]>
     <div>
     <p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:
     .0001pt;text-align:center;line-height:normal;background:#E7E6E6;
     mso-background-themecolor:background2'><b style='mso-bidi-font-weight:
     normal'><span style='font-size:16.0pt;color:black;mso-color-alt:windowtext'>DAY
     3, Tuesday, September 24, 2019</span></b><b style='mso-bidi-font-weight:
     normal'><span style='font-size:16.0pt'><o:p></o:p></span></b></p>
     </div>
     <![if !mso]></td>
    </tr>
   </table>
   <![endif]></v:textbox>
  <w:wrap type="topAndBottom" anchorx="margin"/>
 </v:shape><![endif]--><![if !vml]><img width=497 height=31
 src="agenda1.fld/image005.png"
 alt="Text Box: DAY 3, Tuesday, September 24, 2019" v:shapes="_x0000_s1031"><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>7:00
am - 8:15 am<span style='mso-tab-count:1'>         </span>Registration &amp;
Breakfast<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Session 5<span
style='mso-tab-count:1'>          </span>Late Breaking Topics/Selected Posters<o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Chairs: Omid
Veiseh (Rice Univ)</span></b> &amp; <b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Michael
Mitchell (UPenn) <o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>8:15
am – 8:30 am A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein
complex for in vivo genome editing <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Shaoqin (Sarah) Gong</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>, Vilas
Distinguished Professor, Department of Biomedical Engineering, University of
Wisconsin Madison<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;line-height:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>8:30
am - 8:45 am Steric stabilization of protein-based nanostructures using
elastin-like polypeptides<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>J. Andrew MacKay,</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> Gavin S.
Herbert Associate Professor of Pharmaceutical Sciences, School of Pharmacy,
University of Southern California<o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;line-height:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>8:45am
– 9:00am<span style='mso-spacerun:yes'>  </span>Intelligent Nanomaterials for
Gene, Drug and Nitric Oxide Delivery<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Won Jong Kim</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>, Mueunjae
Chaired Professor, Department of Chemistry, Pohang University of Science and
Technology (POSTECH), South Korea<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a name="_Hlk19708975"><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>9:00 am – 9:15 am<span
style='mso-spacerun:yes'>  </span>Biodegradable Nanoparticles for CRISPR/Cas9
Genome Editing Delivery <o:p></o:p></span></a></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19708975'><b style='mso-bidi-font-weight:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Ming
Wang,</span></b></span><span style='mso-bookmark:_Hlk19708975'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
Professor, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China<o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bookmark:_Hlk19708975'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;text-justify:inter-ideograph;line-height:normal'><span
style='mso-bookmark:_Hlk19708975'><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>9:15 am – 9:30 am Scalable Manufacture of mRNA
Lipid Nanoparticles Using a Novel Microfluidic Mixing Architecture<br>
<b style='mso-bidi-font-weight:normal'>Pratik Goswami,</b><i style='mso-bidi-font-style:
normal'> </i>Precision NanoSystems Inc., Vancouver, BC, Canada. <o:p></o:p></span></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;text-align:
justify;text-justify:inter-ideograph;line-height:normal'><span
style='mso-bookmark:_Hlk19708975'><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></span></p>

<span style='mso-bookmark:_Hlk19708975'></span>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>9:30
am - 9:45 am Discovery of Small Anti-PD-L1 Peptides for Cancer Immunotherapy. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Kun Cheng, </span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Curators'
Distinguished Professor,<b style='mso-bidi-font-weight:normal'> </b>Division of
Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of
Missouri-Kansas City <o:p></o:p></span></p>

<p class=MsoNormal style='margin-top:0in;margin-right:0in;margin-bottom:0in;
margin-left:.5in;margin-bottom:.0001pt;line-height:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>9:45
am – 10:10 am<span style='mso-tab-count:1'>      </span>Coffee Break<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>10:10
am-11:30 am <span style='mso-tab-count:1'>      </span>Poster Presenters<span
style='mso-spacerun:yes'>  </span>(<b style='mso-bidi-font-weight:normal'>Moderator:
Gaurav Sahay (Oregon State Univ)</b>)<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Session 6<span
style='mso-tab-count:1'>          </span>Closing Session<o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoNormal align=center style='margin-bottom:0in;margin-bottom:.0001pt;
text-align:center;line-height:normal'><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Chair:
Qiaobing Xu (Tufts Univ)<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-tab-count:1'>            </span><o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><a name="_Hlk19533389"><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>11:30 am – 12:00 pm</span></a><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> <span
style='mso-tab-count:1'>    </span>Nanoparticle medicated delivery for inner
ear applications<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Zhengyi Chen,</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> Associate
Professor of Otolaryngology, Massachusetts Eye and Ear/MGH<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>12:00
pm - 12:30 pm<span style='mso-tab-count:1'>     </span>Helping biological drugs
to reach their targets<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><b style='mso-bidi-font-weight:normal'><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Maria José Alonso,</span></b><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> Professor
of Pharmacy and Pharmaceutical Technology, University of Santiago de
Compostela, Spain<o:p></o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoNormal style='margin-bottom:0in;margin-bottom:.0001pt;line-height:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>12:30
pm - 12:35 pm<span style='mso-tab-count:1'>     </span>Closing remarks by
conference chair Qiaobing Xu, Tufts University<o:p></o:p></span></p>

<span style='font-size:11.0pt;line-height:107%;font-family:"Calibri",sans-serif;
mso-ascii-theme-font:minor-latin;mso-fareast-font-family:DengXian;mso-fareast-theme-font:
minor-fareast;mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;
mso-ansi-language:EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA'><br
clear=all style='mso-special-character:line-break;page-break-before:always'>
</span></div>

<b style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;
line-height:107%;font-family:"Calibri",sans-serif;mso-ascii-theme-font:minor-latin;
mso-fareast-font-family:DengXian;mso-fareast-theme-font:minor-fareast;
mso-hansi-theme-font:minor-latin;mso-bidi-theme-font:minor-latin;mso-ansi-language:
EN-US;mso-fareast-language:ZH-CN;mso-bidi-language:AR-SA'><br clear=all
style='page-break-before:always;mso-break-type:section-break'>
</span></b>

<div class=WordSection2>

<p class=MsoListParagraphCxSpFirst align=center style='text-align:center'><b
style='mso-bidi-font-weight:normal'><span style='font-size:22.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Posters<o:p></o:p></span></b></p>

<p class=MsoListParagraphCxSpMiddle align=center style='text-align:center'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Day 1. Sept. 22, 2019<o:p></o:p></span></b></p>

<p class=MsoListParagraphCxSpMiddle align=center style='text-align:center'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p>&nbsp;</o:p></span></b></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Self-assembled
nanostructures regulate H<sub>2</sub>S release from constitu-tionally isomeric
peptides. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Yin
Wang</span></u></i><i style='mso-bidi-font-style:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>,
John B. Matson</span></i><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><span style='mso-spacerun:yes'> 
</span>Department of Chemistry, Virginia Tech Center for Drug Discovery, and Macromolecules
Innovation Institute, Virginia Tech, Blacksburg, VA 24061, USA.<b
style='mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>A
novel strategy for oral peptide delivery in incretin-based diabetes treatment. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Yining Xu</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Matthias van Hul<sup>2</sup>, Francesco
Suriano<sup>2</sup>, Véronique Préat<sup>1</sup>, Patrice D. Cani<sup>2*</sup>,
Ana Beloqui<sup>1*</sup></span></i><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Advanced
Drug Delivery and Biomaterials, Louvain Drug Research Institute, Université catholique
de Louvain, 1200 Brussels, Belgium. <sup>2</sup>Metabolism and Nutrition
Research Group, WELBIO (Walloon Excellence in Life sciences and BIOtechnology),
Louvain Drug Research Institute, 1200 Brussels, Belgium.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Ultrasound
responsive theranostic nanobubbles for Rheumatoid Arthritis. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Ekta Singh</span></u></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> and Rinti Banerjee</span></i><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-spacerun:yes'>  </span>Indian Institute of Technology, Mumbai, Maharashtra,
India.<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Peptide
targeting to explore novel biomarker and biology. </span></b><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Yushuang Wei, Tang Tang, <u>Hong-Bo
Pang</u></span></i><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'> University of Minnesota, Minneapolis, MN
55455, USA.<span style='mso-spacerun:yes'>  </span><b style='mso-bidi-font-weight:
normal'><o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Rational
design of personalized nanovaccines and a customized in situ anti-PD-L1 depot
for precise cancer Immunotherapy. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Chunmeng Sun</span></u></i><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-spacerun:yes'>  </span></span></u><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>China
Pharmaceutical University, Nanjing, Jiangsu, China.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>The
Synthesis and Characterization of a Combinatorial Library of Photo-Degradable
Lipidoid Nanoparticles for Drug Delivery Applications. </span></b><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Yamin Li, <u>Anirban Chakraborty</u>,
Jinjin Chen, Qiaobing Xu*</span></i><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> Department of Biomedical Engineering,
Tufts University, Medford, MA 02155, USA. <span
style='mso-spacerun:yes'> </span><b style='mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Bridging
the Gap Between Systemic Vaccine and Mucosal Immunity to Fight Cancer </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Shiran Ferber</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2,3</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Rodrigo J. Gonzalez<sup>4</sup>,
Ulrich H. von Andrian<sup>4,5</sup>, Robert S. Langer<sup>3</sup> and Natalie
Artzi<sup>1,2,6</sup> </span></i><sup><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span style='font-size:
11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Medicine, Engineering in Medicine Division, Brigham and Women’s Hospital,
Harvard Medical School, USA.<span style='mso-spacerun:yes'>  </span><sup>2</sup>Institute
for Medical Engineering and Science, MIT, USA. <sup>3</sup>David H. Koch
Institute for Integrative Cancer Research, MIT, USA. <sup>4</sup>Department of
Immunology, Harvard Medical School, USA. <sup>5</sup>The Ragon Institute of
Massachusetts General Hospital, MIT and Harvard, USA. <sup>6</sup>Broad
Institute of Harvard and MIT, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>8.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Extracellular
Vesicles for DNA Delivery to Brain Endothelial Cells </span></b><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Wanzhu Zhao<sup>1</sup>, Kandarp Dave<sup>1</sup>,
Catherine Hoover<sup>2</sup> and <u>Devika S Manickam</u><sup>1</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-spacerun:yes'>  </span>1</span></sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Duquesne
University, Pittsburgh, PA, USA. <sup>2</sup>Mansfield University, Mansfield,
PA, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>9.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Inhibition
of Neutrophil Inﬁltration and Alcohol-induced liver Injury by Drug-free
E-selectin Targeted Polymer. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Nenad
Milošević</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Marie Ruetter<sup>1</sup>, Yvonne
Ventura<sup>1</sup>, Yarden Kezerle<sup>2</sup>, Valeria Feinshtein<sup>1</sup>,
Ayelet David<sup>1 </sup></span></i><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Clinical Biochemistry and Pharmacology, Faculty of Health Sciences,
Ben-Gurion University of the Negev, Beer-Sheva, Israel. <sup>2</sup>Department
of Pathology, Soroka University Medical Center, Beer-Sheva, Israel.<b
style='mso-bidi-font-weight:normal'> <o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>10.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>A boronic acid-rich dendrimer with
unprecedented efficiency for CRISPR/Cas9 genome editing. </span></b><i
style='mso-bidi-font-style:normal'><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Tao Wan<sup>1</sup>, Yiyun Cheng<sup>2</sup>,
and <u>Yuan Ping</u><sup>1</sup></span></i><sup><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><span style='mso-spacerun:yes'> 
</span>1</span></sup><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:
minor-latin'>College of Pharmaceutical Sciences, Zhejiang University, Hangzhou
310058, China. <sup>2</sup>Shanghai Key Laboratory of Regulatory Biology, East
China Normal University, Shanghai 200241, China.</span><b style='mso-bidi-font-weight:
normal'><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:
minor-latin'><o:p></o:p></span></b></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>11.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Development of redox/pH
dual-responsive nanocarrier with effective endosomal escape for co-delivery of
doxorubicin and siRNA. </span></b><i style='mso-bidi-font-style:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Ting
Su<sup>a</sup>, Lipeng Wu, Xihao Pan, Mingyang Shi, <u>Wei Dong</u><sup>*</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
</span></sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>School of Chemical Engineering, Nanjing
University of Science &amp; Technology, Nanjing 210094, China.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>12.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Development of Irinotecan Silicasome
Nanocarrier for Treatment of Pancreas and Colorectal Cancer </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Xiangsheng Liu</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Huan Meng<sup>1,2,*</sup> and André
E. Nel<sup>1,2,*</sup></span></i><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> <sup>1</sup>Department of Medicine,
Division of NanoMedicine, University of California, Los Angeles, CA, USA. <sup>2</sup>California
NanoSystems Institute, University of California, Los Angeles, CA, USA.<b
style='mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>13.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Formulation and characterization of
polymeric nanoparticles encapsulating anti-inflammatory drugs for improved
delivery. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Blerina
Shkodra-Pula</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Christian Kretzer<sup>3</sup>,
Christian Grune<sup>4</sup>, Antje Vollrath<sup>1,2</sup>, Stephanie Schubert<sup>2,4</sup>,
Dagmar Fischer<sup>4</sup>, Oliver Werz<sup>3,*</sup>, Ulrich S. Schubert<sup>1,2,*</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-spacerun:yes'>  </span>1</span></sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Laboratory for
Organic and Macromolecular Chemistry (IOMC); <sup>2</sup>Jena Center for Soft
Matter (JCSM); <sup>3</sup>Institute of Pharmacy, <sup>4</sup>Pharmaceutical
Technology and Biopharmacy, Friedrich Schiller University Jena, 07743 Jena,
Germany. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>14.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>PLGA based Nanoparticles for the
Management of Surgical Site Infection. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Chetan Dhal</span></u></i><i style='mso-bidi-font-style:
normal'><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:
minor-latin'>*, Renuka Mishra</span></i><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> Institute of
Pharmacy, Nirma University, Ahmedabad, India. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>15.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Discovery of Small Anti-PD-L1 Peptides
for Cancer Immunotherapy. </span></b><i style='mso-bidi-font-style:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Hao
Liu, Zhen Zhao, Li Zhang, Yuanke Li, Akshay Jain, Ashutosh Barve, Wei Jin, <u>Kun
Cheng</u>*</span></i><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'> Division of Pharmacology and Pharmaceutical
Sciences, School of Pharmacy, University of Missouri-Kansas City, Kansas City,
MO 64108. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>16.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Evaluation of In vitro an In vivo
radioprotective activity of bamboo leaf extract. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Mansi Patel</span></u></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Priti Mehta</span></i><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
Institute of Pharmacy, Nirma University, Ahmedabad, India. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>17.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Impact of ionizing radiation on the
stability of select pharmaceuticals. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Dhara Bhayani</span></u></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Priti Mehta</span></i><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
Institute of Pharmacy, Nirma University, Ahmedabad, India.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>18.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Peptide coatings to enhance nanoparticle
diffusivity through tumor extracellular matrix. </span></b><i style='mso-bidi-font-style:
normal'><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:
minor-latin'>R<u>ashmi P Mohanty</u></span></i><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> and Debadyuti
Ghosh The University of Texas at Austin, Austin, Texas, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>19.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Translation of Nanoparticle
Therapeutics from Laboratory Discovery to Clinical Application: Scaled-up production
and solidification. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Chang
Tian</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Jie Feng<sup>2</sup>, Chester E.
Markwalter<sup>1</sup>, Leon Z. Wang<sup>1</sup>, Madeleine Armstrong<sup>1</sup>,
Robert K. Prud’homme<sup>1</sup></span></i><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> 1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Chemical and Biological Engineering, Princeton University, Princeton, New
Jersey, 08540. <sup>2</sup>Department of Mechanical Science and Engineering,
University of Illinois at Urbana-Champaign, Urbana, Illinois, 61801.<b
style='mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>20.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Efficient delivery of antisense oligonucleotides
using bioreducible lipid nanoparticles in vitro and in vivo. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Liu Yang</span></u></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> and Qiaobing Xu</span></i><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
Department of Biomedical Engineering, Tufts University, Medford, MA 02155, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>21.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Nanoparticle Multi-Specific T cell
Engagers for the Treatment of Multiple Myeloma. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Kinan Alhallak</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Julie O’Neal<sup>3</sup>, Jennifer
Sun<sup>1,2</sup>, Barbara Muz<sup>1</sup>, Justin King<sup>3</sup>, Daniel
Kohnen<sup>3</sup>, Samuel Achilefu<sup>4</sup>, Ravi Vij<sup>3</sup>, John F.
DiPersio<sup>3</sup>, and Abdel Kareem Azab<sup>1,2</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
1</span></sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Department of Radiation Oncology; <sup>2</sup>Department
of Biomedical Engineering; <sup>3</sup>Department of Medicine; <sup>4</sup>Department
of Radiology, Washington University School of Medicine, St. Louis, MO, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>22.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Hybrid Metal Organic Framework Nucleic
Acid Nanocapsules for Dual-Regulated Co-Delivery of Biomacromolecules. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Mark Neil Tolentino</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Alyssa Hartman<sup>1</sup>, David
Loe<sup>1</sup>, Shraddha Sawant<sup>1</sup>, Jared Fee<sup>1</sup> and Jessica
Rouge<sup>1,2</sup></span></i><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> <sup>1</sup>Department of Chemistry; <sup>2</sup>Institute
of Materials Science, University of Connecticut, Storrs, Connecticut, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>23.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Endothelial Progenitor Cells as Drug
Delivery Trojan Horses for Theranostic Use in Multiple Myeloma </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Barbara Muz</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Feda Azab<sup>1</sup>, Kinan
Alhallak<sup>1,2</sup>, Jennifer Sun<sup>1,2</sup>, Mensur Koso<sup>1,3</sup>,
Justin King<sup>4</sup>, Mark Fiala<sup>4</sup>, Rui Tang<sup>5</sup>, Partha
Karmakar<sup>5</sup>, Noha N Salama<sup>3</sup>, Ravi Vij<sup>4</sup>, Sam
Achilefu<sup>5</sup> and Abdel Kareem Azab<sup>1,2</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-spacerun:yes'>   </span>1</span></sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department of
Radiation Oncology, Cancer Biology Division; <sup>2</sup>Department of
Biomedical Engineering;<sup> 4</sup>Department of Medicine, Medical Oncology
Division; <sup>5</sup>Department of Radiology, Mallinckrodt Institute of
Radiology, Washington University in St. Louis School of Medicine, St. Louis,
MO, USA. <sup>3</sup>St. Louis College of Pharmacy, Department of
Pharmaceutical and Administrative Sciences, St. Louis, MO; <sup><span
style='mso-spacerun:yes'> </span></sup><b style='mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>24.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Graphene oxide flakes without cationic
functionalization complex and deliver siRNA intracellularly </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Irene de Lázaro</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,3</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Sandra Vranic<sup>1</sup>, Domenico
Marson<sup>2</sup>, Maurizio Buggio<sup>1</sup>, Paola Posocco<sup>2</sup> and
Kostas Kostarelos<sup>1</sup></span></i><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> 1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Nanomedicine
Lab, Faculty of Biology, Medicine and Health &amp;amp; National Graphene Institute,
University of Manchester, Manchester, UK. <sup>2</sup>Molecular Simulation
Engineering Lab, University of Trieste, Trieste, Italy. <sup>3</sup>Present
address: John A. Paulson School of Engineering and Applied Sciences, Harvard
University; Wyss Institute for Biologically Inspired Engineering, Cambridge,
USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>25.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Biodegradable Nanoparticles for
CRISPR/Cas9 Genome Editing Delivery. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Ming Wang</span></u></i><i style='mso-bidi-font-style:
normal'><sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>1</span></sup></i><i style='mso-bidi-font-style:
normal'><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:
minor-latin'>, Qiaobing Xu<sup>2</sup></span></i><sup><span style='font-size:
11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> 1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Institute
of Chemistry, Chinese Academy of Sciences Zhongguancun North First Street 2,
Beijing, China. <sup>2</sup>Department of Biomedical Engineering, Tufts
University, Medford MA 02155, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>26.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Biologically targeted
photo-crosslinkable nano-patch to prevent postsurgical peritoneal adhesion. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Yu Mi</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2,3</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> and Andrew Wang<sup>1,2,3</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
1</span></sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Laboratory of Nano- and Translational
Medicine, Carolina Center for Cancer<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph'><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Nanotechnology Excellence, Carolina Institute
of Nanomedicine; <sup>2</sup>Lineberger Comprehensive Cancer Center; <sup>3</sup>Department
of Radiation Oncology, University of North Carolina at Chapel Hill, Chapel
Hill, North Carolina 27599, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>27.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Biodegradable Nanoparticle Based
Synergistic Combination of Erlotinib and Quinacrine for Advanced Non-Small Cell
Lung Cancer Therapeutics<i style='mso-bidi-font-style:normal'>. </i></span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Nishant S. Kulkarni</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Bhuvaneshwar Vaidya<sup>2,3</sup>
and Vivek Gupta<sup>1,2 </sup></span></i><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>College
of Pharmacy and Health Sciences, St. John’s University, Queens, New York, USA. <sup>2</sup>School
of Pharmacy, Keck Graduate Institute, Claremont, California, USA. <sup>3</sup>School
of Pharmacy, Texas Tech University Health Science Center, Amarillo, Texas, USA.
<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>28.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>H<sub>2</sub>O<sub>2</sub>-responsive
polymer nanoparticles as therapeutic systems for the airway inflammatory
diseases. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Hanui
Lee</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Miran Park<sup>2</sup>, Junwhee Yang<sup>2</sup>,
Dongwon Lee<sup>1,2,*</sup></span></i><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> <sup>1</sup>Department of BIN
Convergence Technology, Chonbuk National University, Baekjedaero 567, Jeonju,
54896, Republic of Korea.<span style='mso-spacerun:yes'>  </span><b
style='mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>29.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Nanoparticle-mediated suicide gene
therapy for triple negative breast cancer treatment. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Lucia Salvioni</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Serena Mazzucchelli<sup>2</sup>,
Fabio Corsi<sup>2,3</sup>, Raffaele De Francesco<sup>4,5</sup>, Davide Prosperi<sup>1,3</sup>,
Riccardo Vago<sup>6,7</sup>, Miriam Colombo<sup>1 </sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>NanoBioLab,
Department of Biotechnology and Biosciences, University of Milano-Bicocca,
Piazza della Scienza 2, 20126, Milan, Italy. <sup>2</sup>Nanomedicina
Laboratory, Department of Biomedical and Clinical Sciences “L. Sacco”, 20157
Milan, Italy. <sup>3</sup>Breast Unit, Surgery Department, ICS Maugeri IRCCS,
27100, Pavia, Italy. <sup>4</sup>INGM – Istituto Nazionale di Genetica
Molecolare “Romeo ed Enrica Invernizzi”, 20122, Milan, Italy. <sup>5</sup>Department
of Pharmacological and Biomolecular Sciences, 20133 Milano, Italy. <sup>6</sup>Urologic
Research Institute, Division of Experimental Oncology, IRCCS San Raffaele
Scientific Institute, 20132, Milan, Italy. <sup>7</sup>Università Vita-Salute
San Raffaele, 20132 Milan, Italy. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>30.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>A theranostic application of
fibrin-responsive nanoparticles for thrombotic vascular diseases. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Junwhee Yang</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> and Hanui Lee<sup>2</sup>, Miran Park<sup>2</sup>,|
Dongwon Lee<sup>1,2,*</sup></span></i><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> <sup>1</sup>Department of BIN
Convergence Technology, Chonbuk National University, Baekjedaero 567, Jeonju,
54896, Republic of Korea. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>31.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Protein Corona Mediates Protein Nanoparticle-Cellular
Interactions. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Samantha
Pustulka</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Kevin Ling<sup>1</sup>, Stephanie
Pish<sup>1</sup>, Julie Champion<sup>1 </sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-spacerun:yes'> </span>1</span></sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Georgia Institute
of Technology, Atlanta, Georgia, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>32.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Endosomal escape enhances cytotoxic T
cell response to polymer-mediated peptide vaccination. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>David J Peeler</span></u></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Albert Yen, Nicholas Luera, Drew L
Sellers, Patrick S Stayton, Suzie H Pun.</span></i><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> Department of
Bioengineering and Molecular Engineering and Sciences Institute, University of
Washington, Seattle, Washington, 98195, USA. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>33.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Polymers and Formulations for Advanced
Nano Drug Delivery Systems. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Jun
Mao</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Rajiv Kumar<sup>1</sup>, Gangadhar
Panambur<sup>1</sup>, Hanying Luo<sup>2</sup>, Nicolynn Davis<sup>2</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Biomedical
Materials R&amp;D; <sup>2</sup>Materials Science Product Management,
MilliporeSigma Inc., Milwaukee, WI 53209, USA. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>34.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Biocompatibility and
macrophage-targeting of mannosylated lipid nanoparticles for tuberculosis
treatment<o:p></o:p></span></b></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph'><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Joana
Magalhães</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Marina Pinheiro<sup>1</sup>, Barbara
Drasler<sup>2</sup>, Dedy Septiadi<sup>2</sup>, Alke Petri-Fink<sup>2</sup>, Susana
G. Santos<sup>3,4</sup>, Barbara Rothen Rutishauser<sup>2</sup>, Salette Reis<sup>1</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
1</span></sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>LAQV, REQUIMTE, Departamento de Ciências
Químicas, Faculdade de Farmácia; <sup>3</sup>i3S - Instituto de Investigação e
Inovação em Saúde, INEB - Instituto de Engenharia Biomédica; <sup>4</sup>ICBAS
- Instituto de Ciências Biomédicas Abel Salazar, Universidade do Porto, Porto,
Portugal. <sup>2</sup>Adolphe Merkle Institute, University of Fribourg,
Fribourg, Switzerland.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>35.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Cellular tropism of plant viral
nanoparticle towards malignant B cells: A novel drug delivery platform for Non-Hodgkin’s
B cell lymphomas. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Sourabh
Shukla</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Anne Jessica Rose<sup>2</sup>, David
Wald<sup>2</sup> and Nicole Steinmetz<sup>1* </sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Nanoengineering,
UC San Diego, La Jolla, California, US. <sup>2</sup>Department of Pathology,
Case Western Reserve University, Cleveland, Ohio, US. <i style='mso-bidi-font-style:
normal'><o:p></o:p></i></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>36.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Nanomedicine for breast cancer
therapy: lipid nanoparticles as targeted drug delivery systems. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Marina Pinheiro</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Andreia Granja<sup>1</sup>, Célia T.
Sousa<sup>3</sup>, Fulvia Farabegoli<sup>4</sup> and Salette Reis<sup>2</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
1</span></sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>LAQV, REQUIMTE, Departamento de Ciências
Químicas, Faculdade de Farmácia; <sup>2</sup>Faculdade de Medicina da
Universidade do Porto; <sup>3</sup>IFIMUP-IN and Departamento de Física e
Astronomia da Faculdade de Ciências da Universidade do Porto, 4169-007 Porto,
Portugal. <sup>4</sup>Department of Experimental Pathology, University of
Bologna, Bologna, Italy. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>37.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>An elastin-like polypeptide fusion
complexes with cyclosporine and modulates IL-2 and IL-17a in Non-Obese Diabetic
mice. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Hao
Guo</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Changrim Lee<sup>1</sup>, Sarah F.
Hamm-Alvarez<sup>1,2</sup>, J. Andrew MacKay<sup>1,2,3 </sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Pharmacology and Pharmaceutical Sciences, School of Pharmacy; <sup>2</sup>Department
of Ophthalmology, Roski Eye Institute and Keck School of Medicine; <sup>3</sup>Department
of Biomedical Engineering, Viterbi School of Engineering, University of Southern
California, Los Angeles, California 90089, United States. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>38.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Novel Electrospun Implant Sonocoated
with nHA Particles for Tissue Engineering Applications. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Julia Higuchi</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2*</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Giuseppino Fortunato<sup>3</sup>,
Bartosz Woźniak<sup>1</sup>, Agnieszka Chodara<sup>1</sup>, Sebastian Domaschke<sup>3,4</sup>,
Alex Dommann<sup>3</sup>, Witold Łojkowski<sup>1</sup> </span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Institute
of High Pressure Physics Polish Academy of Sciences, Warsaw, Poland. <sup>2</sup>Warsaw
University of Technology, Faculty of Materials Science and Engineering, Warsaw,
Poland. <sup>3</sup>Swiss Federal Laboratories for Materials Science and
Technology (EMPA), St. Gallen, Switzerland. <sup>4</sup>Institute for
Mechanical Systems, Swiss Federal Institute of Technology in Zurich (ETHZ),
Zürich, Switzerland. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>39.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>The Importance of Orthogonal
Techniques in Nanoparticle Analysis. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Jean-Luc Fraikin</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Franklin Monzon<sup>1</sup>, Lew
Brown<sup>1</sup>, Ngoc Do<sup>1</sup> and Abigail Lytton-Jean<sup>2</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
1</span></sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Spectradyne, Torrance, CA, USA. <sup>2</sup>The
Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA, USA. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>40.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Influence of endolysosomal pH,
localization and trafficking in multicomponent lipid nanoparticle mediated mRNA
delivery across different tumor cell lines. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Edward J. Sayers</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Samantha E. Peel<sup>2</sup>, Ella
C. Kennett<sup>1</sup>, Bethan Hopkins<sup>1</sup>, Anna Schantz<sup>3</sup>,
Richard M. England<sup>4</sup>, Maya Beano<sup>5</sup>, Stephanie M. Bates<sup>5</sup>,
Arpan S. Desai<sup>6</sup>, Sanyogitta Puri<sup>6</sup>, Marrianne B. Ashford<sup>6</sup>,
Arwyn T. Jones<sup>1<span style='mso-spacerun:yes'>  </span></sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>School
of Pharmacy and Pharmaceutical Sciences, Cardiff University, Redwood Building,
King Edward VII Avenue, Cardiff, CF10 3NB, Wales. <sup>2</sup>Discovery
Biology, Discovery Sciences, IMED Biotech Unit, AstraZeneca, Cambridge, UK. <sup>3</sup>Advanced
Drug Delivery, Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca,
Gothenburg, Sweden. <sup>4</sup>Early Chemical Development, Pharmaceutical
Sciences, IMED Biotech Unit, AstraZeneca, Macclesfield, UK. <sup>5</sup>Pathology,
Drug Safety and Metabolism, IMED Biotech Unit, AstraZeneca, Cambridge, UK. <sup>6</sup>Advanced
Drug Delivery, Pharmaceutical Sciences, IMED Biotech Unit, AstraZeneca,
Cambridge, UK. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>41.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Targeted immune-cell mediated delivery
of redox interventions for the treatment of atherosclerosis. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Sophie Maiocchi</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Jacob Ramsey<sup>2</sup>, Ana
Cartaya<sup>1,2,3</sup>, Marina Sokolsky<sup>2</sup>, Edward Bahnson<sup>1,2,3,4</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-spacerun:yes'>  </span>1</span></sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department of
Surgery; <sup>2</sup>Center for Nanotechnology and Drug Delivery; <sup>3</sup>Department
of Pharmacology; <sup>4</sup>Department of Cell Biology and Physiology,
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>42.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>A biodegradable nanocapsule delivers a
Cas9 ribonucleoprotein complex for in vivo genome editing. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Yuyuan Wang</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Guojun Chen<sup>1,2</sup>, Amr A.
Abdeen<sup>2</sup>, Pawan K. Shahi<sup>3</sup>, Samantha Robertson<sup>4</sup>,
Ruosen Xie<sup>1,2</sup>, Masatoshi Suzuki<sup>4,5</sup>, Bikash R. Pattnaik<sup>3,6</sup>,
Krishanu Saha<sup>2,5 *</sup>, and Shaoqin Gong<sup>1,2,5,7 *</sup> </span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Materials Science and Engineering; <sup>2</sup>Wisconsin Institute for
Discovery; <sup>3</sup>Department of Pediatrics; <sup>4</sup>Department of Comparative
Biosciences; <sup>5</sup>Department of Biomedical Engineering; <sup>6</sup>Department
of Ophthalmology and Visual Sciences; <sup>7</sup>Department of Chemistry,
University of Wisconsin–Madison, Madison, WI 53715, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>43.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Albumin-based nanoparticles for
enhancing the intracellular delivery of Doxorubicin in resistant cancer cell
lines. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Federica
Bessone</span></u></i><i style='mso-bidi-font-style:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>,
Benedetta Ferrara, Chiara Dianzani and Roberta Cavalli<span
style='mso-spacerun:yes'>  </span></span></i><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department of
Drug Science and Technology, University of Turin, Turin, Italy. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>44.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Tunable displacement affinity release
of antibodies towards cancer immunotherapies. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Vincent Huynh</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> and Ryan Wylie<sup>1<span
style='mso-spacerun:yes'>  </span></sup></span></i><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>McMaster
University, Hamilton, Ontario, Canada. <b style='mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>45.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Magnetic targeting improves MSCs
retention in lungs to ameliorate experimental silicosis. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Luisa Silva</span></u></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>¹; Mariana Silva¹; Juliana Vieira¹;
Emília Lima²; Renata Silva³; Fernanda Cruz¹; Patrícia Rocco¹.</span></i><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
¹Laboratory of Pulmonary Investigation, Carlos Chagas Filho Institute of Biophysics,
Federal University of Rio de Janeiro, Av. Carlos Chagas Filho, 373, 21942-902,
Rio de Janeiro, Rio de Janeiro, Brazil. ²Institute of Chemistry, Federal
University of Goiás, Av. Esperança, s/n, 74690-900, Goiânia, Goiás, Brazil. ³National
Institute of Metrology, Quality and Technology (InMetro), Av Nossa Senhora das
Graças, 50, 25250-020, Duque de Caxias, Rio de Janeiro, Brazil. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>46.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Perfluorocarbon-loaded Nanocapsules
Increase X-ray Computed Tomography Contrast of Subcutaneous and Intraperitoneal
Tumors in Mice. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Andre
O’Reilly Beringhs</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Dennis Ndaya<sup>2</sup>, Athina
Kominia<sup>2</sup>, Michael Jay<sup>3</sup>, Rajeswari M. Kasi<sup>2</sup> and
Xiuling Lu<sup>1</sup></span></i><sup><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> 1</span></sup><span style='font-size:
11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Pharmaceutical Sciences; <sup>2</sup>Department of Chemistry, University of
Connecticut, Storrs, CT, USA. <sup>3</sup>Division of Pharmacoengineering and
Molecular Pharmaceutics, Eshelman School of Pharmacy, UNC/NCSU Joint Department
of Biomedical Engineering, University of North Carolina at Chapel Hill, Chapel
Hill, NC, USA. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='text-align:justify;text-justify:
inter-ideograph;text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>47.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Comprehensive Validation of
Nanoliposome Complexes for Protein Replacement Therapy. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Tatjana Michel</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Marina Zieger<sup>2</sup>,
Meike-Kristin Abraham<sup>1</sup>, Christian Mueller<sup>2,3</sup>, Stefanie
Krajewski<sup>1</sup></span></i><sup><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span style='font-size:
11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Thoracic and Cardiovascular Surgery, Clinical Research Laboratory, University
Medical Center, Tuebingen, Germany. <sup>2</sup>The Horae Gene Therapy Center
and Li Weibo Institute for Rare Diseases Research; <sup>3</sup>Department of
Pediatrics, University of Massachusetts Medical School, Worcester MA, USA. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpLast style='text-align:justify;text-justify:inter-ideograph;
text-indent:-.25in;mso-list:l2 level1 lfo2'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>48.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Photoactivatable multiagent
nanoplateform for image-guided surgery and Photodynamic Therapy. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Shazia Bano</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Girgis Obaid<sup>1</sup>, Tayyaba
Hasan<sup>2*</sup></span></i><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> <sup>1</sup>Wellman Center for
Photomedicine, Massachusetts General Hospital and Harvard Medical School,
Boston, Massachusetts, USA. <sup>2</sup>Division of Health Sciences and
Technology, Harvard University and Massachusetts Institute of Technology,
Cambridge, Massachusetts, USA. <o:p></o:p></span></p>

<p class=MsoNormal style='margin-left:.25in;text-align:justify;text-justify:
inter-ideograph'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:
minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraph align=center style='text-align:center'><b
style='mso-bidi-font-weight:normal'><span style='font-size:14.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Day 2. Sept. 23, 2019<o:p></o:p></span></b></p>

<p class=MsoNormal style='margin-left:.25in;text-align:justify;text-justify:
inter-ideograph'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:
minor-latin'><o:p>&nbsp;</o:p></span></p>

<p class=MsoListParagraphCxSpFirst style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>1.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Improved
Re-education of Tumor Associated Macrophages with Arginine-based Poly(I:C)
Nanocomplexes. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Tamara
G. Dacoba</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Clément Anfray<sup>3</sup>,
Francesco Mainini<sup>3</sup>, José Crecente-Campo<sup>1,2</sup>, Paola
Allavena<sup>3</sup>, Fernando Torres Andón<sup>1,3</sup>, María José Alonso<sup>1,2</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-spacerun:yes'>   </span>1</span></sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>CIMUS Research
Institute, School of Pharmacy; <sup>2</sup>Dep. of Pharmacology, Pharmacy and
Pharmaceutical Technology, School of Pharmacy, Universidade de Santiago de
Compostela, Santiago de Compostela, Spain. <sup>3</sup>Clinical and Research
Hospital Humanitas, Istituto di Ricovero e Cura a Carattere Scientifico, Milan,
Italy. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>2.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Interactive,
Polymeric Biomaterials Enhance Drug Delivery in Brain Disease<i
style='mso-bidi-font-style:normal'>. </i></span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Jessica Larsen</span></u></i><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
</span></u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Department of Chemical and Biomolecular
Engineering, Clemson University, Clemson, SC, 29634, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>3.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Non-viral
Intracellular mRNA Delivery into Primary T Lymphocytes Using Synthetic
Lipid-like Nanoparticles.<span style='mso-spacerun:yes'>  </span></span></b><i
style='mso-bidi-font-style:normal'><u><span style='mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Xuewei Zhao</span></u></i><i style='mso-bidi-font-style:
normal'><span style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>,
Jinjin Chen, Min Qiu and Qiaobing Xu.</span></i><span style='mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> Tufts University, Medford, MA, USA. </span><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p></o:p></span></b></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>4.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Surface
functionalized polymersomes for intracellular delivery of Cas9/gRNA ribonucleoprotein
complexes. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Shoaib
Iqbal</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Jessica Larsen<sup>1</sup>, Angela
Alexander-Bryant<sup>2</sup> and Mark Blenner<sup>1</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-spacerun:yes'>  </span>1</span></sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department of
Chemical and Biomolecular Engineering; <sup>2</sup>Department of
Bioengineering, Clemson University, Clemson, SC 29634, USA. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>5.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Hypoxia
sensitive co-delivery system for siRNA and doxorubicin. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Nina Filipczak</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Ujjwal Joshi<sup>1</sup> and
Vladimir Torchilin<sup>1</sup></span></i><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-spacerun:yes'>  </span>1</span></sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Center for
Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston,
MA 02115, USA. <sup>2</sup>Laboratory of Lipids and Liposomes, Department of
Biotechnology, University of Wroclaw, 50-383 Wroclaw, Poland.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>6.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Monoclonal
antibody specifically targets neutrophil extracellular traps (NETs). </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Livia P.Mendes</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Kobra Rostamizadeh<sup>2</sup>,
Kandance Gollomp<sup>3</sup>, Jacob W. Myerson<sup>4</sup>, Oscar A.
Marcos-Contreras<sup>4</sup>, Marco Zamora<sup>4</sup>, Jacob S. Brenner<sup>4,5</sup>,
Ed Luther<sup>6</sup>, Vladimir P.Torchilin<sup>1 </sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Center
for Pharmaceutical Biotechnology and Nanomedicine, Northeastern University, Boston,
MA 02115, USA. <sup>2</sup>Zanjan Pharmaceutical Nanotechnology Research
Center, School of Pharmacy, Pharmaceutical Biomaterials Department, Zanjan
University of Medical Sciences, Zanjan, Iran. <sup>3</sup>Division of
Hematology, Children’s Hospital of Pennsylvania, Philadelphia, PA 19104, USA. <sup>4</sup>Department
of Systems Pharmacology and Translational Therapeutics, Philadelphia, PA 19104,
USA. <sup>5</sup>Pulmonary, Allergy; Critical Care Division, University of
Philadelphia, PA 19104, USA. <sup>6</sup>Department of Pharmaceutical Sciences,
Northeastern University, Boston, MA 02115, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>7.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Impact
of nanomaterial properties on bystander activities induced by TAT-nanoparticles.
</span></b><i style='mso-bidi-font-style:normal'><u><span style='font-size:
11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Yushuang
Wei</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Yuexuan Li<sup>1</sup>, Hongbo Pang<sup>1,*</sup>
</span></i><sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>1</span></sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department of
Pharmaceutics, University of Minnesota, Minneapolis, MN, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>8.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Synthesis
and Characterization of a Computationally Designed Template Mediated Liposome
Nanoparticle. <span style='mso-spacerun:yes'> </span></span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>David Loe</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Zhiqiang Shen<sup>2</sup>, Alessandro
Fisher<sup>2</sup>, Martin Krӧger<sup>3</sup>, Ying Li<sup>2</sup>, and Jessica
Rouge<sup>1</sup></span></i><sup><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span style='font-size:
11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Chemistry; <sup>2</sup>Department of Mechanical Engineering, University of
Connecticut, Storrs, Connecticut, USA <sup>3</sup>Department of Materials,
Polymer Physics, ETH Zürich, CH-8093 Zurich, Switzerland. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>9.<span style='font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Nucleic
Acid Nanocapsule-Based Co-Delivery of siRNA and Au(III) Metallodrugs. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Alyssa K. Hartmann</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Saketh Gudipati<sup>1</sup>, Andrea
Pettenuzzo<sup>2</sup>, Luca Ronconi<sup>2</sup>, Jessica L. Rouge<sup>1*</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
1</span></sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>University of Connecticut, Storrs, CT 06269,
USA. <sup>2</sup>National University of Ireland, Galway, Ireland. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>10.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Branched </span></b><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;font-family:
"Roberts",serif;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Amphipathic</span></b><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> Peptide Capsules – Study of their
cellular uptake mechanisms and intracellular trafficking.<i style='mso-bidi-font-style:
normal'> </i></span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Jonathan
Roberts</span></u></i><i style='mso-bidi-font-style:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>,
Erin McGraw and Adriana Avila Flores</span></i><u><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> </span></u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Biological Sciences, Auburn University, Auburn, AL 36849, USA. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><a name="_Hlk19708882"><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>11.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Scalable Manufacture of mRNA Lipid
Nanoparticles Using a Novel Microfluidic Mixing Architecture. </span></b></a><span
style='mso-bookmark:_Hlk19708882'><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Pratik
Goswami</span></u></i></span><span style='mso-bookmark:_Hlk19708882'><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Jagbir Singh, Gemma Ryan, Ariel
Zhang, James Ko, Andre Wild, Andrew Brown, Samuel Clarke, Lloyd Jeffs, Euan
Ramsay </span></i></span><span style='mso-bookmark:_Hlk19708882'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Precision
NanoSystems Inc., Vancouver, BC, Canada. <o:p></o:p></span></span></p>

<span style='mso-bookmark:_Hlk19708882'></span>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>12.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Polyamidoamine dendrimers-based
nanomedicine for combination therapy with siRNA and hemotherapeutics to
overcome multidrug resistance. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Jiayi
Pan</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Livia P. Mendes<sup>1,3</sup>, Momei
Yao<sup>1</sup>, Nina Filipczak<sup>4</sup>, Sumanta Garai<sup>2</sup>, Ganesh
A. Thakur<sup>2</sup>, Can Sarisozen<sup>1</sup>, Vladimir P. Torchilin<sup>1</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Center
for Pharmaceutical Biotechnology and Nanomedicine; <sup>2</sup>Department of
Pharmaceutical Sciences, Northeastern University, Boston, MA 02115, USA. <sup>3</sup>CAPES
Foundation, Ministry of Education of Brazil, Brasilia 70040-020, Brazil. <sup>4</sup>Laboratory
of Lipids and Liposomes, Department of Biotechnology, University of Wroclaw,
50-383 Wroclaw, Poland. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>13.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Thermo-/pH-responsive Nanoengineered
Chitosan-based Hydrogel as an Injectable and Bio-printed Material for Tissue
Regeneration Applications. </span></b><i style='mso-bidi-font-style:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Panita
Maturavongsadit,<sup>1</sup> Lokesh Karthik Narayanan,<sup>2</sup> Rohan Shirwaiker,<sup>1,2</sup>
<u>S. Rahima Benhabbour</u><sup>*1,3 </sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Joint
Department of Biomedical Engineering, North Carolina State University and The University
of North Carolina at Chapel Hill, Chapel Hill, NC, USA. <sup>2</sup>Edward P.
Fitts Department of Industrial and Systems Engineering, North Carolina State University,
Raleigh, NC, USA. <sup>3</sup>Division of Pharmacoengineering and Molecular
Pharmaceutics, UNC Eshelman School of Pharmacy, University of North Carolina at
Chapel Hill, Chapel Hill, NC, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>14.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>In-Situ Preparation of Gold-Polyester
Nanoshell for Biomedical Imaging. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Mohamed F. Attia</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Meenakshi Ranasinghe<sup>1</sup>,
Roman Akasov<sup>3</sup>, Jeffrey Anker<sup>1</sup>, Daniel C. Whitehead<sup>1</sup>,
and Frank Alexis<sup>2 </sup></span></i><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Chemistry, Clemson University, Clemson, SC, USA. <sup>2</sup>School of
Biological Sciences and Engineering, Yachay Tech, San Miguel de Urcuquí,
Ecuador. <sup>3</sup>National University of Science and Technology «MISIS»,
119991 Moscow, Russia. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>15.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Synthesis and evaluation of
photo-cleavable T 1 -enhanced magnetic resonance imaging drug carrier. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Weihe Yao</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Weihong Qiao<sup>1 </sup></span></i><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>State
Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian,
Liaoning, China.<span style='mso-spacerun:yes'>  </span><o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>16.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Design, synthesis and evaluation of
dual-model targeting contrast agent for PET/MRI. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Ning Wang</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Fangfang Sun<sup>2</sup></span></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-fareast-font-family:
"MS Gothic";mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>,</span></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> Weihong Qiao<sup>1 </sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>State
Key Laboratory of Fine Chemicals, Dalian University of Technology, Dalian,
116024, P. R.China. <sup>2</sup>The First Affiliated Hospital of Dalian Medical
University, Dalian Medical University, Dalian, 116000, P. R. China. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>17.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Highly Swellable Microneedles to
Rapidly Extract Skin Interstitial Fluid for Timely Metabolic Analysis. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Chenjie Xu</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1*</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Mengjia Zheng<sup>1</sup>, Hao Chang<sup>1</sup>,
Benjamin TEE Chee Keong<sup>2</sup></span></i><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> <sup>1</sup>School
of Chemical and Biomedical Engineering, Nanyang Technological University,
637459, Singapore. <sup>2</sup>Department of Materials Science and Engineering,
National University of Singapore, Singapore.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>18.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Prolonged local in vivo delivery of
stimuli-responsive nanogels that rapidly release doxorubicin in triple-negative
breast cancer cells. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Pere
Dosta</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Yi Zhang<sup>1,2</sup>, João Conde<sup>1,2</sup>,
Nuria Oliva<sup>1,2</sup>, Mian Wang<sup>1,2</sup>, Natalie Artzi<sup>1,2,3</sup>
</span></i><sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>1</span></sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Institute for
Medical Engineering and Science, Massachusetts Institute of Technology, Cambridge,
Massachusetts 02139, USA. <sup>2</sup>Engineering in Medicine, Brigham and
Women’s Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA. <sup>3</sup>Broad
Institute of Harvard and MIT, Cambridge, Massachusetts 02139, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>19.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Kinetic Control in Assembly of Plasmid
DNA/Polycation Complex Nanoparticles. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Yizong Hu</span></u></i><i style='mso-bidi-font-style:
normal'><sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i style='mso-bidi-font-style:
normal'><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:
minor-latin'>, Rajat Mittal<sup>3</sup>, Il Minn<sup>*1,4</sup>, and Hai-Quan
Mao<sup>*1,2,5</sup></span></i><sup><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> 1</span></sup><span style='font-size:
11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Institute
for NanoBioTechnology, Departments of <sup>2</sup>Biomedical Engineering, <sup>3</sup>Mechanical
Engineering, <sup>4</sup>Radiology and Radiological Science, <sup>5</sup>Materials
Science and Engineering, Johns Hopkins University and Medicine, Baltimore,
Maryland, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>20.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Field Flow Fractionation for
Characterization of Nanomedicine. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Robert Reed</span></u></i><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-spacerun:yes'>  </span></span></u><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Postnova
Analytics Inc. 230 South 500 East, Salt Lake City, UT 84102, USA<b
style='mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>21.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Designing Inhalable mRNA Therapeutics
for the Rescue of Cystic Fibrosis. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Jeonghwan Kim</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Christopher Acosta<sup>1</sup>,
Antony Jozic<sup>1</sup>, Gaurav Sahay<sup>1,2</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
1</span></sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Department of Pharmaceutical Sciences, College
of Pharmacy, Oregon State University, Robertson Life Science Building,
Portland, Oregon, USA. <sup>2</sup>Department of Biomedical Engineering,
Robertson Life Sciences Building, Oregon Health Science University, Portland,
Oregon, USA. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>22.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Enhanced endosomal escape induced by
lipid nanoparticles with structural polymorphism. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Siddharth Patel</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, N Ashwanikumar<sup>1</sup>, Ema
Robinson<sup>1</sup>, Yan Xia<sup>4</sup>, Joseph P. Griffith III<sup>3</sup>,
Shangguo Hou<sup>3</sup>, Adam E Esposito<sup>4</sup>, Tatiana Ketova<sup>4</sup>,
Cosmin Mihai<sup>4</sup>, John Joyal<sup>4</sup>, Kevin Welsher<sup>3</sup>,
Örn Almarsson<sup>4</sup>, Gaurav Sahay<sup>1,2</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Pharmaceutical Sciences, College of Pharmacy, Oregon State University,
Robertson Life Science Building, 2730 SW Moody Avenue, Portland, Oregon 97201,
USA. <sup>2</sup>Department of Biomedical Engineering, Oregon Health and
Science University, Robertson Life Science Building, 2730 SW Moody Avenue,
Portland, Oregon 97201, USA. <sup>3</sup>Department of Chemistry, Duke
University, Durham, NC 27705, USA. <sup>4</sup>Moderna Therapeutics, 200
Technology Square, Cambridge, MA, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>23.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>A Bioinspired Silk-Elastinlike Protein
Polymer for Cerebral Aneurysm Embolization. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>M. Martin Jensen</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Øyvind Hatlevik<sup>3</sup>, Kyle J.
Isaacson<sup>1,2</sup>, Douglas Steinhauff<sup>1,2</sup>, Zachary B. Barber<sup>1,2</sup>,
Eugene Huo<sup>4,5</sup>, Phil Taussky<sup>6</sup>, Joseph Cappello<sup>4</sup>,
Darwin Cheney<sup>3</sup>, Hamid Ghandehari<sup>1,2,3,4</sup> </span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Biomedical Engineering; <span style='mso-spacerun:yes'> </span><sup>2</sup>Utah
Center for Nanomedicine, Nano Institute of Utah;<sup> 4</sup>Department of
Pharmaceutics and Pharmaceutical Chemistry; <sup>6</sup>Department of
Neurosurgery, University of Utah, Salt Lake City, Utah, USA. <sup>3</sup>TheraTarget,
Inc., Salt Lake City, Utah, USA. <sup>5</sup>Department of Radiology &amp;
Biomedical Imaging, University of California, San Francisco, California, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>24.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Synthesis of mono-dispersal
water-soluble iron oxide nanoparticles with functional groups in polyols for
T1-weighted MRI. </span></b><i style='mso-bidi-font-style:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Pohlee
Cheah, Paul Brown, <u>Yongfeng Zhao </u></span></i><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department of
Chemistry and Biochemistry, College of Science and Technology, Jackson State
University, Jackson, MS 39217, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>25.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Cell Assembly-Mediated Delivery of
Checkpoint Inhibitors for Leukemia Immunotherapy. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Quanyin Hu</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> and Zhen Gu<sup>2* </sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Koch
Institute for Integrative Cancer Research, Massachusetts Institute of
Technology, USA. <sup>2</sup>Department of Bioengineering, California
Nanosystems Institute, University of California, Los Angeles, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>26.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Fenofibrate-loaded biodegradable
nanoparticles for treating diabetic retinopathy. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Tuo Meng</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Fangfang Qiu<sup>2</sup>, Qian Chen<sup>2</sup>,
Kelu Zhou<sup>2</sup>, Yan Shao<sup>2</sup>, Greg Matlock<sup>2</sup>, Xiang Ma<sup>2</sup>,
Wenjing Wu<sup>2</sup>, Yanhong Du<sup>2</sup>, Xiang Wang<sup>2</sup>, Guotao
Deng<sup>2</sup>, Jian-xing Ma<sup>2*, </sup>Qingguo Xu<sup>1*</sup>. </span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Pharmaceutics, Virginia Commonwealth University, Richmond, Virginia 23298,
USA. <sup>2</sup>Department of Physiology, The University of Oklahoma Health
Sciences Center, Oklahoma City, Oklahoma 73104, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>27.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Marble Center for Cancer Nanomedicine.
</span></b><i style='mso-bidi-font-style:normal'><u><span style='font-size:
11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Tarek
Fadel </span></u></i><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Marble Center for Cancer Nanomedicine, Koch
Institute for Integrative Cancer Research, Massachusetts Institute of
Technology, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>28.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Metronomic intraperitoneal
chemotherapy for metastatic ovarian cancer using suturable woven nanotextile
implants. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Smrithi
Padmakumar</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Neha Parayath<sup>2</sup>, Deepthy
Menon<sup>1</sup> &amp; Mansoor M Amiji<sup>2 </sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Centre
for Nanosciences &amp; Molecular Medicine, Amrita Institute of Medical
Sciences, Amrita Vishwa Vidyapeetham, Kochi, India 682041. <sup>2</sup>Department
of Pharmaceutical Sciences, School of Pharmacy, Northeastern University,
Boston, MA 02115, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>29.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Tough Adhesive Clay Composite
Hydrogels for Controlled Drug Delivery. </span></b><sup><span style='font-size:
11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-spacerun:yes'> </span><i style='mso-bidi-font-style:normal'>1,2</i></span></sup><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Esther Koh</span></u></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, <sup>1,2</sup>Benjamin R. Freedman, <sup>3</sup>Andreas
Kuttler, <sup>3</sup>Eckhard Weber, <sup>1,2</sup>David J. Mooney</span></i><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
<sup>1</sup>John A. Paulson School of Engineering and Applied Sciences; <sup>2</sup>Wyss
Institute for Biologically Inspired Engineering, Harvard University, Cambridge,
MA, <sup>3</sup>Novartis, Basel, Switzerland. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>30.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><i style='mso-bidi-font-style:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Frizzled7
Antibody Nanocarriers for Treatment of Triple Negative Breast Cancer . </span></i></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Jianxin Wang</span></u></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Rachel S. Riley, Megan N. Dang,
Emily S. Day</span></i><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'> University of Delaware, Newark, DE, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>31.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Nanoscale Metal-Organic Frameworks
Enhance Radiotherapy and Potentiate Immunotherapy of Cancers. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Kaiyuan Ni</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Guangxu Lan<sup>1</sup>, Christina
Chan<sup>1</sup>, Nining Guo<sup>1,2</sup>, Ralph R. Weichselbaum<sup>2</sup>, and
Wenbin Lin<sup>1,2,*</sup> </span></i><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Chemistry; <sup>2</sup>Department of Radiation and Cellular Oncology, University
of Chicago, Chicago, IL 60637, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>32.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Accelerating Nanomedicine Development
- from Proof of Concept to Clinical Trials. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Matthew Wingate</span></u></i><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>,
Director of Process Development Phosphorex, Inc., Hopkinton, MA, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>33.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Positively Charged Superparamagnetic
Iron Oxide Nanoworms: A Pilot Study of Labeling CD123 CAR-T Cells for Treatment
of Myelodysplastic Syndrome. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Guankui
Wang</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Wei Zhang<sup>3</sup>, Ernest V.
Groman<sup>1,2</sup>, Fangfang Chen<sup>1,4</sup>, Enkhtsetseg Purev<sup>3</sup>
and Dmitri Simberg<sup>1,2 </sup></span></i><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical
Sciences; <sup>2</sup>Colorado Center for Nanomedicine and Nanosafety, Skaggs
School of Pharmacy and Pharmaceutical Sciences; <sup>3</sup>Divison of
Hematology, Department of Medicine, University of Colorado Anschutz Medical
Campus, Aurora, CO, USA. <sup>4</sup>Department of Gastrointestinal Surgery,
China-Japan Union Hospital, Jilin University, Changchun, Jilin, P.R.China.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>34.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Dendrimer-based Antibiotics for the
Treatment of Bacterial Biofilms. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Younan
Ma</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Rodrigo S. Heyder<sup>1</sup>,
Dennis Ohman<sup>2</sup>, and Sandro R. P. da Rocha<sup>1</sup> </span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Pharmaceutics and Center for Pharmaceutical Engineering and Sciences, School
of Pharmacy; <sup>2</sup>Department of Microbiology and Immunology, Virginia
Commonwealth University, Richmond, VA, USA. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>35.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Poly(ester-anhydride) Gemcitabine:
Synthesis and Particle Engineering of a High Payload Drug Delivery System. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Rodrigo S. Heyder</span></u></i><i
style='mso-bidi-font-style:normal'><sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> and Sandro R. P. da Rocha<sup>1<span
style='mso-spacerun:yes'>  </span></sup></span></i><sup><span style='font-size:
11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Pharmaceutics and Center for Pharmaceutical Engineering and Sciences, School
of Pharmacy, Virginia Commonwealth University, Richmond, VA 23284, USA<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>36.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Megalin-targeting Liposomes for
Placental Drug Delivery. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Ali
Alfaifi</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2,3</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Rodrigo S. Heyder<sup>2,3</sup>,
Elizabeth Bielski<sup>2,3</sup>, Rashed Almuqbil<sup>2,3</sup>, Mahendra Kavdia<sup>1</sup>,
Phillip M. Gerk<sup>2</sup> and Sandro R. P. da Rocha<sup>2,3,* </sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department
of Biomedical Engineering, Wayne State University, Detroit, MI, USA. <sup>2</sup>Department
of Pharmaceutics; <sup>3</sup>Center for Pharmaceutical Engineering and
Sciences, School of Pharmacy, Virginia Commonwealth University, Richmond, VA,
USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>37.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Manufacture of Lipid and Polymer Drug
Delivery Systems Using Novel NxGen Microfluidic Technology. </span></b><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>S. Abraham, S. G. Talluri, H. Son; <u>P.
Goswami</u>, R. Gupta, A.W. Wild, K. Marshall, B. Versteeg, M. Kerin, M.
Fellows, M. Ma, J. Ko, S. Clarke, A. Thomas </span></i><span style='font-size:
11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Precision
NanoSystems Inc, Vancouver, BC, Canada.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><i style='mso-bidi-font-style:
normal'><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:
minor-latin'><span style='mso-list:Ignore'>38.<span style='font:7.0pt "Times New Roman"'>&nbsp;
</span></span></span></i><![endif]><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Self-assembled
nanozymes for immune cell mediated targeted delivery of antioxidants to the
damaged vasculature. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Ana
E. Cartaya</span></u></i><i style='mso-bidi-font-style:normal'><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>1,2,3</span></sup></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> and Edward M. Bahnson<sup>1,2,3,4</sup>
</span></i><sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>1</span></sup><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department of
Surgery, <sup>2</sup>Center for Nanotechnology and Drug Delivery, <sup>3</sup>Department
of Pharmacology, <sup>4</sup>Department of Cell Biology and Physiology,
University of North Carolina at Chapel Hill, Chapel Hill, NC, USA. <i
style='mso-bidi-font-style:normal'><o:p></o:p></i></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>39.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Bridging the Gap Between Systemic
Vaccine and Mucosal Immunity to Fight Cancer. </span></b><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Alexander
M. Cryer</span></u><sup><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>1,2</span></sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>,
Shiran Ferber<sup>1,2,3</sup>, Noah Gorelick<sup>4</sup>, Betty Tyler<sup>4</sup>,
Henry Brem<sup>4</sup>, Robert S. Langer<sup>3</sup> and Natalie Artzi<sup>1,2,5</sup>
<sup>1</sup>Department of Medicine, Engineering in Medicine Division, Brigham
and Women’s Hospital, Harvard Medical School, USA. <sup>2</sup>Institute for
Medical Engineering and Science, <sup>3</sup>David H. Koch Institute for
Integrative Cancer Research, MIT, USA. <sup>4</sup>Department of Neurosurgery,
Johns Hopkins Hospital, Baltimore, MD, USA. <sup>5</sup>Broad Institute of
Harvard and MIT, USA. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>40.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>In Vivo Lipid Nanoparticle-Mediated
Cas9 delivery efficiently edits muscle tissue and can restore function of the
Dystrophin gene in a mouse model of DMD. </span></b><i style='mso-bidi-font-style:
normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Zachary Glass</span></u></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Dr. Yamin Li, Dr. Min Qiu, Dr.
Qiaobing Xu </span></i><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>Department of Biomedical Engineering, Tufts
University, Medford, MA, USA.<o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>41.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Engineered Mucoadhesive
Silk-Elastin-Like Proteins for Transmucosal Drug Delivery and Drug Screening. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Rachael N. Parker</span></u></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>, Wenyao A. Wu, Tina B. McKay,
Qiaobing Xu, David L. Kaplan. </span></i><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Department of
Biomedical Engineering, Tufts University, Medford, MA 02155, USA. <o:p></o:p></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>42.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>High Capacity poly(2-oxazoline)
formulation of immunoadjuvant extends survival in a chemo insensitive,&nbsp;metastatic
model of Lung Adenocarcinoma. </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Natasha
Vinod<sup>1,2</sup></span></u></i><i style='mso-bidi-font-style:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>,&nbsp;Duhyeong&nbsp;Hwang<sup>1</sup>
, Salma&nbsp;H.&nbsp;Azam<sup>3</sup> , Amanda E. D.&nbsp;Van&nbsp;Swearingen<sup>3</sup>,
Elizabeth Wayne<sup>1</sup>,&nbsp;Sloane Christian Fussell<sup>4</sup>,&nbsp;Marina
Sokolsky-Papkov<sup>1</sup>, Chad V. Pecot <sup>3,5,6</sup>
,&nbsp;and&nbsp;Alexander V. Kabanov <sup>1,7</sup></span></i><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
&nbsp;1 Center for Nanotechnology&nbsp;in Drug Delivery and Division
of&nbsp;Pharmacoengineering&nbsp;and Molecular Pharmaceutics, Eshelman School
of Pharmacy, University of North Carolina at Chapel Hill, 2 Joint UNC/NC State
Department of Biomedical Engineering, 3 Lineberger Comprehensive Cancer Center,
UNC&nbsp; 4 Department of Biology, UNC&nbsp; 5 Division of Hematology &amp;amp;
Oncology, UNC 6 Department of Medicine, UNC&nbsp; 7 Laboratory of Chemical
Design of Bionanomaterials, Faculty of Chemistry, M.V. Lomonosov Moscow State
University, Moscow, Russia.<b style='mso-bidi-font-weight:normal'> <o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>43.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Poly(2-oxazoline) micelles improve the
delivery and efficacy of vismodegib for brain tumor therapy in
medulloblastoma-prone mice </span></b><i style='mso-bidi-font-style:normal'><u><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>Duhyeong
Hwang<sup>1</sup></span></u></i><i style='mso-bidi-font-style:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
, Taylor Dismuke <sup>2</sup> , John R. Kagel <sup>3</sup> , Chaemin Lim <sup>1</sup>
, William Zamboni <sup>3</sup>, Alexander V. Kabanov <sup>1</sup> , Timothy R.
Gershon <sup>4,5</sup> and Marina Sokolsky-Papkov<sup> 1</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
</span></sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'><span style='mso-spacerun:yes'> </span>1
Center for Nanotechnology&nbsp;in Drug Delivery, Eshelman School of Pharmacy,
University of North Carolina at Chapel Hill, 2 Department of Pathology and
Laboratory Medicine, UNC. 3 Division of Pharmacotherapy and Experimental
Therapeutics, Eshelman School of Pharmacy, UNC 4 Department of Neurology,
UNC<span style='mso-spacerun:yes'>  </span>5 Lineberger Comprehensive Cancer
Center, UNC<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpMiddle style='margin-left:40.5pt;mso-add-space:
auto;text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;
mso-list:l0 level1 lfo5'><![if !supportLists]><span style='font-size:11.0pt;
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>44.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Evaluating the efficiency of delivery
of lipophilic cargo to bone marrow via cell-based carriers. </span></b><i
style='mso-bidi-font-style:normal'><u><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'>Chunyan Yang</span></u></i><i
style='mso-bidi-font-style:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'> <sup>1</sup> , Ping Ren <sup>2</sup>
, Laren Lofchy <sup>3</sup> , Hanmant Gaikwad <sup>3 </sup>, Fangfang Chen <sup>3,4
*</sup> and Dmitri Simberg <sup>3 *</sup></span></i><sup><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'>
</span></sup><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'>1 Department of Cardiology, China-Japan Union
Hospital, Jilin University, 126 Xiantai Street, Changchun, Jilin, China 2
Department of Thoracic Surgery, The First Hospital of Jilin University, 71
Xinmin Street, Changchun, Jilin, China 3 Department of Pharmaceutical Sciences,
Skaggs School of Pharmacy and Pharmaceutical Sciences, University of Colorado
Anschutz Medical Campus, Aurora, CO, USA 4 Department of Gastrointestinal
Surgery, China-Japan Union Hospital, Jilin University, 126 Xiantai Street,
Changchun, Jilin, China<b style='mso-bidi-font-weight:normal'><o:p></o:p></b></span></p>

<p class=MsoListParagraphCxSpLast style='margin-left:40.5pt;mso-add-space:auto;
text-align:justify;text-justify:inter-ideograph;text-indent:-.25in;mso-list:
l0 level1 lfo5;background:white;mso-background-themecolor:background1'><![if !supportLists]><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><span
style='mso-list:Ignore'>45.<span style='font:7.0pt "Times New Roman"'>&nbsp; </span></span></span><![endif]><b
style='mso-bidi-font-weight:normal'><span style='font-size:11.0pt;mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin;color:black;mso-color-alt:windowtext'>Targeting
peripheral leukemic tumor cells with iron nanoparticles: Role of surface
properties and complement opsonization. </span></b><i style='mso-bidi-font-style:
normal'><span style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:
minor-latin;color:black;mso-color-alt:windowtext'>Wen Wu <sup>1</sup> ,
Yuansong Bai<sup>1</sup> , Yi Liu<sup>1</sup> , Jingrui Cao<sup>1 </sup>,
Yongli Dong<sup>1</sup> , Zhaoyi Wang<sup>1</sup> , Guankui Wang 2, Ping Ren<sup>2,3
</sup>, Dmitri Simberg<sup>2 *</sup>, <u>Fangfang Chen</u><sup>1,2,4*</sup></span></i><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;
color:black;mso-color-alt:windowtext'>1 Department of Nanomedicine, China-Japan
Union Hospital of Jilin University, Changchun, Jilin, China. 2 Department of
Pharmaceutical Sciences, Skaggs School of Pharmacy and Pharmaceutical Sciences,
University of Colorado Anschutz Medical Campus, Aurora, CO, USA. 3 The First
Hospital of Jilin University, Changchun, Jilin, China. 4 State Key Laboratory
of Inorganic Synthesis and Preparative Chemistry, College of Chemistry, Jilin
University, Changchun</span><b style='mso-bidi-font-weight:normal'><span
style='font-size:11.0pt;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p></o:p></span></b></p>

<p class=MsoNormal align=center style='text-align:center'><a name="_Hlk19526721"><b
style='mso-bidi-font-weight:normal'><span style='font-size:26.0pt;line-height:
107%;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#C00000'>Sponsors<o:p></o:p></span></b></a></p>

<p class=MsoNormal align=center style='text-align:center;line-height:150%'><!--[if gte vml 1]><o:wrapblock><v:shape
  id="Picture_x0020_15" o:spid="_x0000_s1030" type="#_x0000_t75" style='position:absolute;
  left:0;text-align:left;margin-left:17pt;margin-top:38.15pt;width:477.5pt;
  height:40pt;z-index:251668480;visibility:visible;mso-wrap-style:square;
  mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
  mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
  mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
  mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
  mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
  mso-width-relative:page;mso-height-relative:page'>
  <v:imagedata src="agenda1.fld/image006.png" o:title=""/>
  <w:wrap type="topAndBottom" anchorx="margin"/>
 </v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0>
  <tr>
   <td width=7 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=478 height=40 src="agenda1.fld/image006.png" v:shapes="Picture_x0020_15"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='mso-bookmark:_Hlk19526721'></span><span style='mso-bookmark:_Hlk19526721'><b
style='mso-bidi-font-weight:normal'><u><span style='font-size:28.0pt;
line-height:150%;font-family:"Edwardian Script ITC";mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin;color:#C45911;mso-themecolor:accent2;
mso-themeshade:191'>Platinum</span></u></b></span><span style='mso-bookmark:
_Hlk19526721'><b style='mso-bidi-font-weight:normal'><u><span style='font-size:
28.0pt;line-height:150%;font-family:"Edwardian Script ITC";mso-bidi-font-family:
Calibri;mso-bidi-theme-font:minor-latin'><o:p></o:p></span></u></b></span></p>

<p class=MsoNormal align=center style='text-align:center'><!--[if gte vml 1]><o:wrapblock><v:shape
  id="Picture_x0020_7" o:spid="_x0000_s1029" type="#_x0000_t75" alt="sinopeg"
  style='position:absolute;left:0;text-align:left;margin-left:159.6pt;
  margin-top:63.5pt;width:171.75pt;height:58.45pt;z-index:251667456;
  visibility:visible;mso-wrap-style:square;mso-width-percent:0;
  mso-height-percent:0;mso-wrap-distance-left:9pt;mso-wrap-distance-top:0;
  mso-wrap-distance-right:9pt;mso-wrap-distance-bottom:0;
  mso-position-horizontal:absolute;mso-position-horizontal-relative:margin;
  mso-position-vertical:absolute;mso-position-vertical-relative:text;
  mso-width-percent:0;mso-height-percent:0;mso-width-relative:page;
  mso-height-relative:page'>
  <v:imagedata src="agenda1.fld/image007.png" o:title="sinopeg"/>
  <w:wrap type="topAndBottom" anchorx="margin"/>
 </v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0>
  <tr>
   <td width=150 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=171 height=59 src="agenda1.fld/image007.png" alt=sinopeg
   v:shapes="Picture_x0020_7"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='mso-bookmark:_Hlk19526721'></span><span style='mso-bookmark:_Hlk19526721'><b
style='mso-bidi-font-weight:normal'><u><span style='font-size:28.0pt;
line-height:107%;font-family:"Edwardian Script ITC";mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin;color:#C45911;mso-themecolor:accent2;
mso-themeshade:191'>Gold </span></u></b></span><span style='mso-bookmark:_Hlk19526721'><b
style='mso-bidi-font-weight:normal'><u><span style='font-size:28.0pt;
line-height:107%;font-family:"Edwardian Script ITC";mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin'><span style='mso-spacerun:yes'>     </span><o:p></o:p></span></u></b></span></p>

<p class=MsoNormal align=center style='text-align:center;line-height:200%'><!--[if gte vml 1]><o:wrapblock><v:shape
  id="Picture_x0020_3" o:spid="_x0000_s1028" type="#_x0000_t75" style='position:absolute;
  left:0;text-align:left;margin-left:33.9pt;margin-top:90.55pt;width:422.65pt;
  height:110.9pt;z-index:251672576;visibility:visible;mso-wrap-style:square;
  mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
  mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
  mso-wrap-distance-bottom:0;mso-position-horizontal:absolute;
  mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
  mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
  mso-width-relative:page;mso-height-relative:page'>
  <v:imagedata src="agenda1.fld/image008.png" o:title=""/>
  <w:wrap type="topAndBottom" anchorx="margin"/>
 </v:shape><![endif]--><![if !vml]><span style='mso-ignore:vglayout'>
 <table cellpadding=0 cellspacing=0>
  <tr>
   <td width=24 height=0></td>
  </tr>
  <tr>
   <td></td>
   <td><img width=423 height=111 src="agenda1.fld/image008.png" v:shapes="Picture_x0020_3"></td>
  </tr>
 </table>
 </span><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='mso-bookmark:_Hlk19526721'></span><span style='mso-bookmark:_Hlk19526721'><b
style='mso-bidi-font-weight:normal'><u><span style='font-size:28.0pt;
line-height:200%;font-family:"Edwardian Script ITC";mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin;color:#C45911;mso-themecolor:accent2;
mso-themeshade:191'>Silver</span></u></b></span><span style='mso-bookmark:_Hlk19526721'><b
style='mso-bidi-font-weight:normal'><u><span style='font-family:"Edwardian Script ITC";
mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin;color:#C45911;
mso-themecolor:accent2;mso-themeshade:191'><o:p></o:p></span></u></b></span></p>

<p class=MsoNormal align=center style='margin-top:12.0pt;text-align:center;
line-height:200%'><!--[if gte vml 1]><o:wrapblock><v:shape id="Picture_x0020_4"
  o:spid="_x0000_s1027" type="#_x0000_t75" style='position:absolute;left:0;
  text-align:left;margin-left:0;margin-top:122.55pt;width:461.15pt;height:77.8pt;
  z-index:251673600;visibility:visible;mso-wrap-style:square;
  mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
  mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
  mso-wrap-distance-bottom:0;mso-position-horizontal:center;
  mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
  mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
  mso-width-relative:page;mso-height-relative:page'>
  <v:imagedata src="agenda1.fld/image009.png" o:title=""/>
  <w:wrap type="topAndBottom" anchorx="margin"/>
 </v:shape><![endif]--><![if !vml]><img width=462 height=77
 src="agenda1.fld/image009.png" v:shapes="Picture_x0020_4"><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='mso-bookmark:_Hlk19526721'></span><span style='mso-bookmark:_Hlk19526721'><b
style='mso-bidi-font-weight:normal'><u><span style='font-size:36.0pt;
line-height:200%;font-family:"Edwardian Script ITC";mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin;color:#C45911;mso-themecolor:accent2;
mso-themeshade:191'>B</span></u></b></span><span style='mso-bookmark:_Hlk19526721'><b
style='mso-bidi-font-weight:normal'><u><span style='font-size:28.0pt;
line-height:200%;font-family:"Edwardian Script ITC";mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin;color:#C45911;mso-themecolor:accent2;
mso-themeshade:191'>ronze</span></u></b></span><span style='mso-bookmark:_Hlk19526721'><b
style='mso-bidi-font-weight:normal'><span style='font-size:28.0pt;line-height:
200%;mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'> </span></b></span><span
style='mso-bookmark:_Hlk19526721'><b style='mso-bidi-font-weight:normal'><span
style='mso-bidi-font-family:Calibri;mso-bidi-theme-font:minor-latin'><o:p></o:p></span></b></span></p>

<p class=MsoNormal align=center style='margin-top:12.0pt;text-align:center;
line-height:200%'><!--[if gte vml 1]><o:wrapblock><v:shape id="Picture_x0020_22"
  o:spid="_x0000_s1026" type="#_x0000_t75" style='position:absolute;left:0;
  text-align:left;margin-left:0;margin-top:82.15pt;width:447pt;height:101.3pt;
  z-index:251671552;visibility:visible;mso-wrap-style:square;
  mso-width-percent:0;mso-height-percent:0;mso-wrap-distance-left:9pt;
  mso-wrap-distance-top:0;mso-wrap-distance-right:9pt;
  mso-wrap-distance-bottom:0;mso-position-horizontal:center;
  mso-position-horizontal-relative:margin;mso-position-vertical:absolute;
  mso-position-vertical-relative:text;mso-width-percent:0;mso-height-percent:0;
  mso-width-relative:page;mso-height-relative:page'>
  <v:imagedata src="agenda1.fld/image010.png" o:title=""/>
  <w:wrap type="topAndBottom" anchorx="margin"/>
 </v:shape><![endif]--><![if !vml]><img width=447 height=101
 src="agenda1.fld/image010.png" v:shapes="Picture_x0020_22"><![endif]><!--[if gte vml 1]></o:wrapblock><![endif]--><br
style='mso-ignore:vglayout' clear=ALL>
<span style='mso-bookmark:_Hlk19526721'></span><span style='mso-bookmark:_Hlk19526721'><b
style='mso-bidi-font-weight:normal'><u><span style='font-size:28.0pt;
line-height:200%;font-family:"Edwardian Script ITC";mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin;color:#C45911;mso-themecolor:accent2;
mso-themeshade:191'>Poster Awards Sponsors</span></u></b></span><span
style='mso-bookmark:_Hlk19526721'></span><b style='mso-bidi-font-weight:normal'><u><span
style='font-family:"Edwardian Script ITC";mso-bidi-font-family:Calibri;
mso-bidi-theme-font:minor-latin;color:#C45911;mso-themecolor:accent2;
mso-themeshade:191'><o:p></o:p></span></u></b></p>

</div>

</body>

</html>
